AzTrials
AzTrials

Solid TumorsPhase 3NCT03486873

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

A Phase 3 study testing Pembrolizumab, Lenvatinib and Olaparib in people with Solid Tumors and Hematologic Malignancies, run by Merck Sharp & Dohme LLC at 782 sites in 51 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Solid Tumors, Hematologic Malignancies
What is being tested?
Pembrolizumab, Lenvatinib and Olaparib
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,500 participants
Where
782 sitesin 51 countries
Study dates
21 Aug 2018to 4 Aug 2043
Phase
Phase 3

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Treated on the parent pembrolizumab studies established by the Sponsor as MK-3475-587 ready.
  • Currently receiving pembrolizumab, pembrolizumab based combinations or lenvatinib from parent studies or in a follow-up phase.
  • Additional eligibility criteria for participants who enter Second Course Phase once they are enrolled on MK-3475-587:
  • Has not received any anticancer systemic treatment since the last dose of pembrolizumab or a pembrolizumab-based combination in First Course Phase.
  • Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
  • Demonstrates adequate organ function.
Show all 12Show fewer
  • Have resolution of any toxic effect(s) of First Course Phase trial treatment with pembrolizumab or a pembrolizumab-based combination to Grade 1 or less (except alopecia) before trial treatment in Second Course Phase is started. If participant received major surgery or radiation therapy of >30 Gray (Gy), they must have recovered from the toxicity and/or complications of the intervention.
  • A female participant is eligible to enroll if she is not pregnant, not breastfeeding, and ≥1 of the following conditions applies: A woman of childbearing potential (WOCBP) who agrees to use contraception during the study treatment period and for ≥120 days (corresponding to time needed to eliminate any study combination treatment(s) plus 30 days (a menstruation cycle) for study treatments with risk of genotoxicity.
  • Additional eligibility criteria for participants who enter dosing with Lenvatinib:
  • Adequately controlled blood pressure (BP) to <150/90 mmHg, with or without antihypertensive medications.
  • For male agrees to be abstinent from penile-vaginal intercourse OR agrees to use a highly effective contraceptive method while receiving study drug and for 7 days after the last dose of lenvatinib.
  • Is female and not pregnant/breastfeeding and at least one of the following applies during the study and for ≥4 days after: is not a woman of childbearing potential (WOCBP), is a WOCBP and uses highly effective contraception (low user dependency method OR a user dependent hormonal method in combination with a barrier method) or is a WOCBP who is abstinent from heterosexual intercourse.

Who cannot join

  • -There are no exclusion criteria to participate in MK-3475-587.
  • Participants are excluded from entering Second Course trial treatment once they are enrolled on MK-3475-587 if any of the following criteria applies:
  • Has severe hypersensitivity (≥ Grade 3) to pembrolizumab and/or any of its excipients.
  • Has received a live vaccine within 30 days prior to the first dose of Second Course Phase trial treatment.
  • Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the Cycle 1 Day 1 of Second Course Phase.
  • Has a known additional malignancy that is progressing or requires active treatment. Exceptions include early stage cancers (carcinoma in situ or Stage 1) treated with curative intent, melanoma (non-ulcerated, thin primary), basal cell carcinoma of the skin, squamous cell carcinoma of the skin, in situ cervical cancer, or in situ breast cancer that has undergone potentially curative therapy.
Show all 31Show fewer
  • Has known active central nervous system metastases and/or carcinomatous meningitis.
  • Has an active autoimmune disease that has required systemic treatment in the past 2 years (i.e., use of disease modifying agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment and is allowed.
  • Has a history of (non-infectious) pneumonitis that required steroids or has current pneumonitis. Note: Participants that experienced pneumonitis during First Course that did not meet the criteria for permanent discontinuation are eligible.
  • Non-small cell lung cancer (NSCLC) participants only: Has interstitial lung disease.
  • Has an active infection requiring systemic therapy.
  • Has a known history of human immunodeficiency virus (HIV) infection.
  • Has a known history of or is positive for hepatitis B or hepatitis C. For parent studies where inclusion of participants with hepatitis was permitted, MK-3475-587 will follow the parent study eligibility criteria for hepatitis.
  • Is pregnant or breastfeeding or expecting to conceive or father children within the projected duration of the study, starting with the Second Course Phase eligibility Visit through 120 days after the last dose of study treatment.
  • Has severe cardiovascular disease, i.e., arrhythmias, requiring chronic treatment, congestive heart failure (New York Heart Association Class III or IV) or symptomatic ischemic heart disease.
  • Has hepatic decompensation (Child-Pugh score >6 [class B and C]).
  • Has uncontrolled thyroid dysfunction.
  • Has uncontrolled diabetes mellitus.
  • Has had an allogeneic tissue/solid organ transplant.
  • Has a known history of active tuberculosis (TB; Bacillus tuberculosis).
  • Additional exclusion criteria for participants who enter dosing with Lenvatinib:
  • Has had major surgery within 3 weeks prior to first dose of study intervention(s).
  • Has preexisting ≥Grade 3 gastrointestinal or non-gastrointestinal fistula.
  • Has urine protein ≥1 g/24 hours.
  • Has LVEF below the institutional (or local laboratory) normal range, as determined by multigated acquisition scan (MUGA) or echocardiogram (ECHO).
  • Has radiographic evidence of encasement or invasion of a major blood vessel, or of intratumoral cavitation.
  • Prolongation of QT intervals corrected for heart rate using Fridericia's (cube root) correction (QTcF) interval to >480 ms.
  • Has clinically significant cardiovascular disease within 12 months from first dose of study intervention, including New York Heart Association Class III or IV congestive heart failure, unstable angina, myocardial infarction, cerebral vascular accident, or cardiac arrhythmia associated with hemodynamic instability.
  • Gastrointestinal malabsorption or any other condition that might affect the absorption of lenvatinib.
  • Active hemoptysis (bright red blood of at least 0.5 teaspoon) within 3 weeks prior to the first dose of study drug.
  • Has a history of any contraindication or has a severe hypersensitivity to any components of lenvatinib.

Trial locations and contacts

782 sites in 51 countries. Contact the study team or a site near you to ask about taking part.

Toll Free Number contact

1-888-577-8839

Trialsites@msd.com

782 sites in 51 countries

Japan87 sites, 41 recruiting

  • Hyogo Cancer Center ( Site 3131)

    Akashi, Hyōgo, 673-8558

    Study Coordinator, +81-78-929-1151

    Recruiting

  • Institute of Science Tokyo Hospital ( Site 3149)

    Bunkyō, Tokyo, 113-8519

    Completed

  • Chiba Cancer Center ( Site 3117)

    Chiba, 260-8717

    Study Coordinator, +81-43-264-5431

    Recruiting

  • National Hospital Organization Kyushu Medical Center ( Site 3136)

    Fukuoka, 810-8563

    Completed

  • National Hospital Organization Kyushu Cancer Center ( Site 3169)

    Fukuoka, 811-1395

    Completed

  • Kyushu University Hospital ( Site 3143)

    Fukuoka, 812-8582

    Completed

  • Kyushu University Hospital ( Site 3185)

    Fukuoka, 812-8582

    Completed

  • Gifu University Hospital ( Site 3161)

    Gifu, 501-1112

    Completed

  • University of the Ryukyus Hospital ( Site 3155)

    Ginowan, Okinawa, 901-2725

    Study Coordinator, +81-98-894-1301

    Recruiting

  • Osaka Habikino Medical Center ( Site 3138)

    Habikino, Osaka, 583-8588

    Completed

  • Saitama Medical University International Medical Center ( Site 3118)

    Hidaka, Saitama, 350-1298

    Study Coordinator, +81-42-984-4111

    Recruiting

  • National Hospital Organization Himeji Medical Center ( Site 3111)

    Himeji, Hyōgo, 670-8520

    Study Coordinator, +81-79-225-3211

    Recruiting

  • Kansai Medical University Hospital ( Site 3126)

    Hirakata, Osaka, 573-1191

    Study Coordinator, +81-72-804-0101

    Recruiting

  • Hiroshima City Hiroshima Citizens Hospital ( Site 3119)

    Hiroshima, 730-8518

    Completed

  • Hiroshima University Hospital ( Site 3154)

    Hiroshima, 734-8551

    Completed

  • Kanazawa University Hospital ( Site 3140)

    Kanazawa, Ishikawa-ken, 920-8641

    Study Coordinator, +81-76-265-2000

    Recruiting

  • Ibaraki Prefectural Central Hospital ( Site 3180)

    Kasama, Ibaraki, 309-1793

    Study Coordinator, +81-296-78-0021

    Recruiting

  • Nara Medical University Hospital ( Site 3110)

    Kashihara, Nara, 634-8522

    Completed

  • National Cancer Center Hospital East ( Site 3121)

    Kashiwa, Chiba, 2778577

    Study Coordinator, +81-4-7133-1111

    Recruiting

  • Nippon Medical School Musashi Kosugi Hospital ( Site 3178)

    Kawasaki, Kanagawa, 211-8533

    Study Coordinator, +81-44-733-5181

    Recruiting

  • St. Marianna University Hospital ( Site 3182)

    Kawasaki, Kanagawa, 216-8511

    Completed

  • Kagawa University Hospital ( Site 3171)

    Kita, Kagawa-ken, 761-0701

    Completed

  • Saitama Prefectural Cancer Center ( Site 3112)

    Kitaadachi-gun, Saitama, 362-0806

    Study Coordinator, +81-48-722-1111

    Recruiting

  • Kobe City Medical Center General Hospital ( Site 3144)

    Kobe, Hyōgo, 650-0047

    Completed

  • Kochi Health Sciences Center ( Site 3145)

    Kochi, 781-8555

    Completed

  • Dokkyo Medical University Saitama Medical Center ( Site 3152)

    Koshigaya, Saitama, 3438555

    Completed

  • Cancer Institute Hospital of JFCR ( Site 3146)

    Koto, Tokyo, 135-8550

    Study Coordinator, +81-3-3520-0111

    Recruiting

  • Cancer Institute Hospital of JFCR ( Site 3164)

    Koto, Tokyo, 135-8550

    Study Coordinator, +81-3-3520-0111

    Recruiting

  • Kumamoto University Hospital ( Site 3179)

    Kumamoto, 860-8556

    Completed

  • Kurashiki Central Hospital ( Site 3132)

    Kurashiki, Okayama-ken, 710-8602

    Completed

  • Kurume University Hospital ( Site 3105)

    Kurume, Fukuoka, 830-0011

    Study Coordinator, +81942353311

    Recruiting

  • Kyoto University Hospital ( Site 3181)

    Kyoto, 606-8507

    Completed

  • National Hospital Organization Shikoku Cancer Center ( Site 3116)

    Matsuyama, Ehime, 791-0280

    Completed

  • Toranomon Hospital ( Site 3189)

    Minato, Tokyo, 105-8470

    Study Coordinator, +81-3-3588-1111

    Recruiting

  • Toranomon Hospital ( Site 3134)

    Minato-ku, Tokyo, 105-8470

    Study Coordinator, +81-3-3588-1111

    Recruiting

  • Toranomon Hospital ( Site 3153)

    Minato-ku, Tokyo, 105-8470

    Completed

  • Kyorin University Hospital ( Site 3103)

    Mitaka, Tokyo, 181-8611

    Study Coordinator, +81422475511

    Recruiting

  • Kyorin University Hospital ( Site 3147)

    Mitaka-shi, Tokyo, 181-8611

    Completed

  • National Hospital Organization Nagoya Medical Center ( Site 3109)

    Nagoya, Aichi-ken, 460-0001

    Study Coordinator, +81-52-951-1111

    Recruiting

  • Aichi Cancer Center ( Site 3101)

    Nagoya, Aichi-ken, 464-8681

    Study Coordinator, +81527626111

    Recruiting

  • Nagoya University Hospital ( Site 3151)

    Nagoya, Aichi-ken, 466-8560

    Study Coordinator, +81-52-741-2111

    Recruiting

  • Shizuoka Cancer Center ( Site 3128)

    Nakatogari, Shizuoka, 411-8777

    Study Coordinator, +81-55-989-5222

    Recruiting

  • Miyagi Cancer Center ( Site 3122)

    Natori-shi, Miyagi, 981-1293

    Completed

  • Niigata Cancer Center Hospital ( Site 3173)

    Niigata, Niigata, 951-8566

    Completed

  • Niigata University Medical & Dental Hospital ( Site 3174)

    Niigata, 951-8520

    Study Coordinator, +81252236161

    Recruiting

  • Hyogo Medical University Hospital ( Site 3100)

    Nishinomiya, Hyōgo, 663-8501

    Study Coordinator, +81798456111

    Recruiting

  • Okayama University Hospital ( Site 3107)

    Okayama, 700-8558

    Study Coordinator, +81-86-223-7151

    Recruiting

  • Osaka City General Hospital ( Site 3125)

    Osaka, 534-0021

    Completed

  • National Hospital Organization Osaka National Hospital ( Site 3162)

    Osaka, 540-0006

    Study Coordinator, +81669421331

    Recruiting

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3129)

    Osaka, 541-8567

    Study Coordinator, +81669451181

    Recruiting

  • Osaka General Medical Center ( Site 3184)

    Osaka, 558-8558

    Completed

  • Kitasato University Hospital ( Site 3142)

    Sagamihara, Kanagawa, 252-0375

    Study Coordinator, +81-42-778-8111

    Recruiting

  • Kindai University Hospital ( Site 3102)

    Sakai, Osaka, 590-0197

    Study Coordinator, +81723660221

    Recruiting

  • Kindai University Hospital ( Site 3135)

    Sakai, Osaka, 590-0197

    Completed

  • Kindai University Hospital ( Site 3166)

    Sakai, Osaka, 590-0197

    Completed

  • Osaka Rosai Hospital ( Site 3148)

    Sakai, Osaka, 591-8025

    Study Coordinator, +81-72-252-3561

    Recruiting

  • National Hospital Organization Hokkaido Cancer Center ( Site 3160)

    Sapporo, Hokkaido, 003-0804

    Completed

  • Sapporo Kosei General Hospital ( Site 3172)

    Sapporo, Hokkaido, 060-0033

    Completed

  • Sapporo Medical University Hospital ( Site 3113)

    Sapporo, Hokkaido, 060-8543

    Study Coordinator, +81-11-611-2111

    Recruiting

  • Hokkaido University Hospital ( Site 3165)

    Sapporo, Hokkaido, 060-8648

    Completed

  • Tohoku University Hospital ( Site 3175)

    Sendai, Miyagi, 980-8574

    Study Coordinator, +81-22-717-7000

    Recruiting

  • Sendai Kousei Hospital ( Site 3115)

    Sendai, Miyagi, 981-0914

    Active, not recruiting

  • Jichi Medical University Hospital ( Site 3141)

    Shimotsuke, Tochigi, 329-0498

    Completed

  • Showa Medical University Hospital ( Site 3188)

    Shinagawa, Tokyo, 142-8666

    Study Coordinator, +81-3-3784-8000

    Recruiting

  • Tokyo Medical University Hospital ( Site 3170)

    Shinjuku-ku, Tokyo, 160-0023

    Completed

  • Iwate Medical University Hospital ( Site 3157)

    Shiwa-gun, Iwate, 028-3695

    Completed

  • The University of Osaka Hospital ( Site 3168)

    Suita, Osaka, 565-0871

    Completed

  • Osaka Medical and Pharmaceutical University Hospital ( Site 3167)

    Takatsuki, Osaka, 569-8686

    Completed

  • Osaka Medical and Pharmaceutical University Hospital ( Site 3187)

    Takatsuki, Osaka, 569-8686

    Study Coordinator, +81-72-683-1221

    Recruiting

  • National Defense Medical College Hospital ( Site 3177)

    Tokorozawa, Saitama, 359-8513

    Study Coordinator, +81-4-2995-1682

    Recruiting

  • National Cancer Center Hospital ( Site 3130)

    Tokyo, 104-0045

    Study Coordinator, +81-3-3542-2511

    Recruiting

  • St.Luke's International Hospital ( Site 3120)

    Tokyo, 104-8560

    Completed

  • The Jikei University Hospital ( Site 3156)

    Tokyo, 105-8471

    Active, not recruiting

  • Nippon Medical School Hospital ( Site 3139)

    Tokyo, 113-8603

    Completed

  • Tokyo Metropolitan Komagome Hospital ( Site 3133)

    Tokyo, 113-8677

    Study Coordinator, +81-3-3823-2101

    Recruiting

  • Cancer Institute Hospital of JFCR ( Site 3108)

    Tokyo, 135-8550

    Study Coordinator, +81335200111

    Recruiting

  • Keio University Hospital ( Site 3127)

    Tokyo, 160-8582

    Active, not recruiting

  • Teikyo University Hospital ( Site 3104)

    Tokyo, 173-8606

    Completed

  • Ehime University Hospital ( Site 3158)

    Tōon, Ehime, 791-0295

    Study Coordinator, +81-89-960-5910

    Recruiting

  • Toyama Prefectural Central Hospital ( Site 3183)

    Toyama, 930-8550

    Completed

  • University of Tsukuba Hospital ( Site 3176)

    Tsukuba, Ibaraki, 305-8576

    Study Coordinator, +81-29-853-3900

    Recruiting

  • National Hospital Organization Yamaguchi Ube Medical Center ( Site 3123)

    Ube, Yamaguchi, 755-0241

    Completed

  • Yamaguchi University Hospital ( Site 3114)

    Ube, Yamaguchi, 755-8505

    Completed

  • Wakayama Medical University Hospital ( Site 3124)

    Wakayama, 641-8510

    Study Coordinator, +81-73-447-2300

    Recruiting

  • Yokohama City University Hospital ( Site 3163)

    Yokohama, Kanagawa, 236-0004

    Completed

  • Kanagawa Cancer Center ( Site 3137)

    Yokohama, Kanagawa, 241-8515

    Study Coordinator, +81-45-520-2222

    Recruiting

  • Yokosuka Kyosai Hospital ( Site 3150)

    Yokosuka, Kanagawa, 238-8558

    Completed

Other trials in Japan

United States65 sites, 39 recruiting

  • Emory School of Medicine ( Site 0013)

    Atlanta, Georgia, 30322

    Completed

  • Augusta University ( Site 0077)

    Augusta, Georgia, 30912

    Completed

  • University of Colorado Cancer Center ( Site 0021)

    Aurora, Colorado, 80045

    Study Coordinator, 720-848-7135

    Recruiting

  • Texas Oncology - Central/South Texas ( Site 8001)

    Austin, Texas, 78745

    Study Coordinator, 512-447-2202

    Recruiting

  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054)

    Bakersfield, California, 93309

    Study Coordinator, 661-322-2206

    Recruiting

  • MedStar Franklin Square Medical Center ( Site 0046)

    Baltimore, Maryland, 21237

    Study Coordinator, 443-777-7364

    Recruiting

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056)

    Baltimore, Maryland, 21287

    Study Coordinator, 410-955-5222

    Recruiting

  • Fred Hutchinson Cancer Center ( Site 0024)

    Bellevue, Washington, 98004

    Study Coordinator, 206-606-8245

    Recruiting

  • Massachusetts General Hospital ( Site 0041)

    Boston, Massachusetts, 02114

    Active, not recruiting

  • Dana-Farber Cancer Institute ( Site 0006)

    Boston, Massachusetts, 02215

    Active, not recruiting

  • WakeMed Cancer Care - Waverly Hematology & Medical Oncology ( Site 0074)

    Cary, North Carolina, 27518

    Active, not recruiting

  • University of North Carolina at Chapel Hill ( Site 0040)

    Chapel Hill, North Carolina, 27514

    Study Coordinator, 919-843-7713

    Recruiting

  • Levine Cancer Institute ( Site 0034)

    Charlotte, North Carolina, 28204

    Active, not recruiting

  • University of Virginia Health System ( Site 0035)

    Charlottesville, Virginia, 22908

    Study Coordinator, 434-243-6303

    Recruiting

  • The University of Chicago ( Site 0020)

    Chicago, Illinois, 60637

    Study Coordinator, 773-834-7961

    Recruiting

  • University Hospitals ( Site 0044)

    Cleveland, Ohio, 44106

    Completed

  • Maryland Oncology Hematology (MOH) ( Site 8000)

    Columbia, Maryland, 21044

    Study Coordinator, 410-964-2212

    Recruiting

  • Women's Cancer Care ( Site 0088)

    Covington, Louisiana, 70433

    Study Coordinator, 985-317-6005

    Recruiting

  • Texas Oncology-Baylor Sammons Cancer Center ( Site 0062)

    Dallas, Texas, 75246

    Study Coordinator, 214-370-1000

    Recruiting

  • Karmanos Cancer Institute ( Site 0047)

    Detroit, Michigan, 48201

    Study Coordinator, 800-527-6266

    Recruiting

  • Duke Cancer Center ( Site 0028)

    Durham, North Carolina, 27710

    Study Coordinator, 919-668-3771

    Recruiting

  • St. Luke's University Health Network ( Site 0017)

    Easton, Pennsylvania, 18045

    Completed

  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065)

    Fargo, North Dakota, 58102

    Completed

  • Holy Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022)

    Fort Lauderdale, Florida, 33308

    Study Coordinator, 954-776-3036

    Recruiting

  • California Cancer Associates for Research & Excellence ( Site 0016)

    Fresno, California, 93720

    Completed

  • Providence Medical Foundation ( Site 0087)

    Fullerton, California, 92835

    Completed

  • West Cancer Center and Research Institute ( Site 0055)

    Germantown, Tennessee, 38138

    Completed

  • Saint Francis Health System ( Site 0089)

    Greenville, South Carolina, 29607

    Completed

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0038)

    Hackensack, New Jersey, 07601

    Active, not recruiting

  • Kaiser Permanente Moanalua Medical Center ( Site 0063)

    Honolulu, Hawaii, 96819

    Completed

  • University of Texas MD Anderson Cancer Center ( Site 0007)

    Houston, Texas, 77030

    Study Coordinator, 713-792-2921

    Recruiting

  • University of Iowa Hospital and Clinics ( Site 0026)

    Iowa City, Iowa, 52242

    Study Coordinator, 319-356-1228

    Recruiting

  • Baptist MD Anderson Cancer Center ( Site 0083)

    Jacksonville, Florida, 32207

    Completed

  • Comprehensive Cancer Centers of Nevada ( Site 0043)

    Las Vegas, Nevada, 89169

    Study Coordinator, 702-952-3400

    Recruiting

  • The Angeles Clinic and Research Institute ( Site 0005)

    Los Angeles, California, 90025

    Active, not recruiting

  • UCLA - Hematology/Oncology - Administrative Office ( Site 0009)

    Los Angeles, California, 90095

    Study Coordinator, 310-794-6913

    Recruiting

  • James Graham Brown Cancer Center ( Site 0058)

    Louisville, Kentucky, 40202

    Study Coordinator, 502-562-4673

    Recruiting

  • Northwest Georgia Oncology Centers PC ( Site 0061)

    Marietta, Georgia, 30060

    Study Coordinator, 770-281-5124

    Recruiting

  • Mount Sinai Braman Comprehensive Cancer Center ( Site 0031)

    Miami Beach, Florida, 33140

    Study Coordinator, 305-674-2625

    Recruiting

  • Bon Secours St. Francis Medical Center-Oncology Research ( Site 0075)

    Midlothian, Virginia, 23114

    Completed

  • Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060)

    Nashville, Tennessee, 37204

    Study Coordinator, 615-936-6726

    Recruiting

  • Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015)

    Nashville, Tennessee, 37232

    Study Coordinator, 615-936-6726

    Recruiting

  • Cancer Institute of New Jersey ( Site 0025)

    New Brunswick, New Jersey, 08901

    Study Coordinator, 917-991-4174

    Recruiting

  • Yale Cancer Center ( Site 0014)

    New Haven, Connecticut, 06510

    Completed

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032)

    New York, New York, 10016

    Study Coordinator, 212-731-5431

    Recruiting

  • Memorial Sloan Kettering Cancer Center ( Site 0012)

    New York, New York, 10065

    Completed

  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0076)

    Orange, California, 92868

    Completed

  • Mercy Health-Paducah Cancer Center ( Site 0084)

    Paducah, Kentucky, 42003

    Study Coordinator, 270-441-4343

    Recruiting

  • Stanford Cancer Center ( Site 0086)

    Palo Alto, California, 94304

    Study Coordinator, 650-721-7489

    Recruiting

  • University of Pennsylvania ( Site 0010)

    Philadelphia, Pennsylvania, 19104

    Study Coordinator, 215-662-7908

    Recruiting

  • Fox Chase Cancer Center ( Site 0042)

    Philadelphia, Pennsylvania, 19111

    Study Coordinator, 215-214-4297

    Recruiting

  • UPMC Hillman Cancer Center ( Site 0008)

    Pittsburgh, Pennsylvania, 15232

    Study Coordinator, 412-623-3272

    Recruiting

  • Providence Portland Medical Center ( Site 0051)

    Portland, Oregon, 97225

    Completed

  • VCU Health Adult Outpatient Pavillion ( Site 0080)

    Richmond, Virginia, 23219

    Study Coordinator, 804-628-6430

    Recruiting

  • Blue Ridge Cancer Care ( Site 0067)

    Roanoke, Virginia, 24014

    Study Coordinator, 540-491-2244

    Recruiting

  • Mayo Clinic in Rochester, Minnesota ( Site 0002)

    Rochester, Minnesota, 55905

    Active, not recruiting

  • South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001)

    San Antonio, Texas, 78229

    Study Coordinator, 210-593-5265

    Recruiting

  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004)

    San Francisco, California, 94158

    Study Coordinator, 415-514-6382

    Recruiting

  • Providence Saint John's Health Center ( Site 0059)

    Santa Monica, California, 90404

    Study Coordinator, 310-449-5244

    Recruiting

  • Sanford Cancer Center ( Site 0066)

    Sioux Falls, South Dakota, 57104

    Completed

  • Moffitt Cancer Center ( Site 0011)

    Tampa, Florida, 33612

    Completed

  • Arizona Cancer Center at UMC North ( Site 0018)

    Tucson, Arizona, 85719

    Study Coordinator, 520-694-1053

    Recruiting

  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082)

    Tulsa, Oklahoma, 74146

    Study Coordinator, 918-505-3200

    Recruiting

  • Georgetown University Medical Center ( Site 0023)

    Washington D.C., District of Columbia, 20007

    Active, not recruiting

  • White Plains Hospital-Center for Cancer Care ( Site 0069)

    White Plains, New York, 10601

    Study Coordinator, 914-849-7630

    Recruiting

Other trials in United States

China57 sites, 53 recruiting

  • Beijing Cancer Hospital ( Site 3451)

    Beijing, Beijing Municipality, 100035

    Study Coordinator, 010-88121122

    Recruiting

  • The Fifth Medical Center Of The Chinese PLA General Hospital (South) ( Site 3465)

    Beijing, Beijing Municipality, 100071

    Study Coordinator, 861066947161

    Recruiting

  • Beijing Cancer Hospital ( Site 3499)

    Beijing, Beijing Municipality, 100142

    Study Coordinator, +861088196100

    Recruiting

  • Beijing Cancer Hospital ( Site 3500)

    Beijing, Beijing Municipality, 100142

    Study Coordinator, +861088197746

    Recruiting

  • Beijing Cancer hospital-Thoracic Cancer Department A ( Site 3454)

    Beijing, Beijing Municipality, 100142

    Study Coordinator, 010-88121122

    Recruiting

  • Chinese Academy of medical science, Peking Union Medical College Hospital(Dongdan) ( Site 3466)

    Beijing, Beijing Municipality, 100730

    Study Coordinator, (010)69158883

    Recruiting

  • The First Hospital of Jilin University-Oncology ( Site 3464)

    Changchun, Jilin, 130021

    Study Coordinator, 0431-88782222

    Recruiting

  • Jilin Province Tumor Hospital ( Site 3484)

    Changchun, Jilin, 132000

    Study Coordinator, 0431-80596607

    Recruiting

  • Xiangya Hospital Central South University ( Site 3508)

    Changsha, Hunan, 410008

    Study Coordinator, 0731-89753999

    Recruiting

  • Xiangya Hospital Central South University-Gynecology ( Site 3497)

    Changsha, Hunan, 410008

    Study Coordinator, +86073189753999

    Recruiting

  • Xiangya Hospital Central South University-Respiratory ( Site 3479)

    Changsha, Hunan, 410008

    Active, not recruiting

  • Hunan Cancer Hospital ( Site 3485)

    Changsha, Hunan, 410013

    Study Coordinator, 0731-88651900

    Recruiting

  • Hunan Cancer Hospital ( Site 3501)

    Changsha, Hunan, 410013

    Study Coordinator, 0731-88651900

    Recruiting

  • West China Hospital Sichuan University-respiratory ( Site 3473)

    Chengdu, Sichuan, 610041

    Active, not recruiting

  • Sichuan Cancer hospital. ( Site 3515)

    Chengdu, Sichuan, 610213

    Study Coordinator, +862885420305

    Recruiting

  • Army Medical Center of People's Liberation Army-Oncology Department ( Site 3477)

    Chongqing, Chongqing Municipality, 400042

    Study Coordinator, 13908338998

    Recruiting

  • Fujian Provincial Cancer Hospital ( Site 3461)

    Fuzhou, Fujian, 350014

    Study Coordinator, +8659187487329

    Recruiting

  • Southern medical university Nangfang Hospital ( Site 3490)

    Guanghzou, Guangdong, 510515

    Study Coordinator, 020-61641888

    Recruiting

  • The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 3491)

    Guangzhou, Guangdong, 510000

    Study Coordinator, 020 3825 4110

    Recruiting

  • SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal Medicine ( Site 3452)

    Guangzhou, Guangdong, 510030

    Study Coordinator, +862087343535

    Recruiting

  • Sun Yat-sen University Cancer Center-melanoma ( Site 3482)

    Guangzhou, Guangdong, 510060

    Study Coordinator, +8659187487329

    Recruiting

  • Guangdong Provincial People's Hospital-Cancer Center ( Site 3462)

    Guangzhou, Guangdong, 510080

    Study Coordinator, +8602083827812

    Recruiting

  • The First Affiliated Hospital, Sun Yat-sen University-pneumology department ( Site 3459)

    Guangzhou, Guangdong, 510080

    Study Coordinator, +862087333133

    Recruiting

  • The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 3460)

    Guangzhou, Guangdong, 510120

    Study Coordinator, +862083062755

    Recruiting

  • Nanfang Hospital of Southern Medical University ( Site 3509)

    Guangzhou, Guangdong, 510515

    Study Coordinator, 020-62786847

    Recruiting

  • The Affiliated Cancer Hospital of Guizhou Medical University ( Site 3498)

    Guiyang, Guizhou, 550008

    Study Coordinator, 0851-86812999

    Recruiting

  • Women s Hospital School of Medicine Zhejiang University ( Site 3493)

    Hangzhou, Zhejiang, 310001

    Study Coordinator, 0571-89992071

    Recruiting

  • Hangzhou Cancer Hospital-Medical Oncology ( Site 3468)

    Hangzhou, Zhejiang, 310002

    Study Coordinator, 13735430109

    Recruiting

  • The First Affiliated Hospital of Zhejiang University ( Site 3518)

    Hangzhou, Zhejiang, 310003

    Study Coordinator, 057187236560

    Recruiting

  • Sir Run Run Shaw Hospital ( Site 3505)

    Hangzhou, Zhejiang, 310016

    Study Coordinator, 0571-86090073

    Recruiting

  • Zhejiang Cancer Hospital ( Site 3481)

    Hangzhou, Zhejiang, 310022

    Study Coordinator, 13588832760

    Recruiting

  • Zhejiang Cancer Hospital ( Site 3495)

    Hangzhou, Zhejiang, 310022

    Study Coordinator, +86 13750851650

    Recruiting

  • Harbin Medical University Cancer Hospital ( Site 3506)

    Harbin, Heilongjiang, 150081

    Study Coordinator, +8613945095085

    Recruiting

  • Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital ( Site 3475)

    Harbin, Heilongjiang, 150081

    Study Coordinator, 0451-86298000

    Recruiting

  • Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 3487)

    Hefei, Anhui, 230036

    Study Coordinator, 18963789187

    Recruiting

  • Anhui Provincial Hospital ( Site 3480)

    Hefei, Anhui, 230071

    Study Coordinator, +8655162283760

    Recruiting

  • Shandong Cancer Hospital ( Site 3517)

    Jinan, Shandong, 250117

    Study Coordinator, +86053167626073

    Recruiting

  • LinYi Cancer Hospital ( Site 3511)

    Linyi, Shandong, 276000

    Study Coordinator, 0539-8121800

    Recruiting

  • The First Affiliated Hospital of Nanchang University ( Site 3513)

    Nanchang, Jiangxi, 30006

    Study Coordinator, 0791-88695051

    Recruiting

  • Jiangsu Cancer Hospital-Medical Oncotherapy ( Site 3469)

    Nanjing, Jiangsu, 210009

    Study Coordinator, 8613901581264

    Recruiting

  • Fudan University Shanghai Cancer Center ( Site 3467)

    Shanghai, Shanghai Municipality, 200032

    Study Coordinator, +86 13636382225

    Recruiting

  • Zhongshan Hospital of Fudan University ( Site 3503)

    Shanghai, Shanghai Municipality, 200032

    Study Coordinator, 021-64041990

    Recruiting

  • Obstetrics & Gynecology Hospital of Fudan University ( Site 3494)

    Shanghai, Shanghai Municipality, 200090

    Study Coordinator, 021-33189900

    Recruiting

  • Shanghai Pulmonary Hospital ( Site 3470)

    Shanghai, Shanghai Municipality, 200433

    Study Coordinator, 8613817918714

    Recruiting

  • Fourth Hospital of Hebei Medical University ( Site 3520)

    Shijiazhuang, Hebei, 050011

    Active, not recruiting

  • Tianjin Medical University Cancer Institute and Hospital ( Site 3456)

    Tianjin, Tianjin Municipality, 300060

    Study Coordinator, 022-23109106

    Recruiting

  • Xinjiang Medical University Cancer Hospital - Urumqi-galactophore department ( Site 3486)

    Ürümqi, Xinjiang, 830000

    Study Coordinator, 0991-7968088

    Recruiting

  • The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 3502)

    Ürümqi, Xinjiang, 841100

    Study Coordinator, 0991-7968088

    Recruiting

  • Tongji Hospital Tongji Medical,Science & Technology-oncology ( Site 3476)

    Wuhan, Hubei, 430000

    Completed

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3492)

    Wuhan, Hubei, 430022

    Study Coordinator, 027 8572 6754

    Recruiting

  • Tangdu Hospital of Fourth Military Medical University of Chi-department of radiotherapy ( Site 3455)

    Xi'an, Shaanxi, 710038

    Study Coordinator, 029-84777777

    Recruiting

  • The First Affiliated Hospital of Xiamen University ( Site 3514)

    Xiamen, Fujian, 361003

    Study Coordinator, 0592-2139767

    Recruiting

  • The First Affiliated Hospital of Xi an Jiaotong University ( Site 3489)

    XiAn, Shanxi, 710061

    Study Coordinator, 029-58324600

    Recruiting

  • Yancheng First People s Hospital ( Site 3504)

    Yancheng, Jiangsu, 224005

    Study Coordinator, 0515-66696800

    Recruiting

  • Northern Jiangsu People's Hospital-General Surgery Department ( Site 3474)

    Yangzhou, Jiangsu, 225000

    Study Coordinator, 13813194298

    Recruiting

  • The Second People's Hospital of Yibin ( Site 3516)

    Yibin, Sichuan, 644000

    Study Coordinator, 0831-2381106

    Recruiting

  • Henan Cancer Hospital ( Site 3488)

    Zhengzhou, Henan, 450008

    Study Coordinator, 0371-65587588

    Recruiting

Other trials in China

France49 sites, 43 recruiting

  • Clinique de L'Europe ( Site 2548)

    Amiens, Somme, 80000

    Study Coordinator, +33360125235

    Recruiting

  • Institut Sainte Catherine ( Site 2557)

    Avignon, Vaucluse, 84918

    Study Coordinator, +33490276397

    Recruiting

  • CHU-Jean Minjoz ( Site 2550)

    Besançon, Doubs, 25000

    Study Coordinator, +33381479999

    Recruiting

  • CHU Jean Minjoz ( Site 2520)

    Besançon, Doubs, 25030

    Completed

  • Hôpital Avicenne-Dermatologie ( Site 2538)

    Bobigny, Seine-Saint-Denis, 93000

    Completed

  • Institut Bergonie ( Site 2502)

    Bordeaux, Gironde, 33076

    Study Coordinator, +33556333333

    Recruiting

  • Ambroise Pare Hopital ( Site 2503)

    Boulogne, Hauts-de-Seine, 92104

    Study Coordinator, +33149095673

    Recruiting

  • CHRU Brest - Hopital Cavale Blanche ( Site 2504)

    Brest, Finistere, 29200

    Study Coordinator, +33298223578

    Recruiting

  • Centre Francois Baclesse ( Site 2558)

    Caen, Calvados, 14076

    Study Coordinator, +33231455015

    Recruiting

  • Hopital Trousseau ( Site 2512)

    Chambray-lès-Tours, Indre-et-Loire, 37170

    Completed

  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 2542)

    Clermont-Ferrand, Puy-de-Dome, 63003

    Study Coordinator, +33473278137

    Recruiting

  • Hôpital Beaujon ( Site 2524)

    Clichy, Île-de-France Region, 92110

    Study Coordinator, +33140875614

    Recruiting

  • Centre Hospitalier Intercommunal de Créteil ( Site 2514)

    Créteil, Val-de-Marne, 94010

    Study Coordinator, +33157022101

    Recruiting

  • HENRI MONDOR HOSPITAL ( Site 2561)

    Créteil, Val-de-Marne, 94010

    Study Coordinator, +330149814182

    Recruiting

  • Centre Georges François Leclerc-Centre de recherche clinique ( Site 2536)

    Dijon, Cote-d Or, 21079

    Study Coordinator, +33380737751

    Recruiting

  • Centre Hospitalier Annecy Genevois ( Site 2554)

    Epagny Metz Tessy, Haute-Savoie, 74730

    Active, not recruiting

  • Centre Hospitalier du Mans-Pneumologie ( Site 2527)

    Le Mans, Sarthe, 72000

    Study Coordinator, +33243432764

    Recruiting

  • Centre Oscar Lambret ( Site 2551)

    Lille, Hauts-de-France, 59020

    Study Coordinator, +33320295959

    Recruiting

  • CHRU Lille Hospital Claude Huriez ( Site 2506)

    Lille, Nord, 59037

    Study Coordinator, +33320444193

    Recruiting

  • Centre Hopitalar Leon-Berard ( Site 2519)

    Lyon, Auvergne, 69373

    Study Coordinator, +33478782654

    Recruiting

  • Hopital Nord ( Site 2516)

    Marseille, Bouches-du-Rhone, 13015

    Study Coordinator, +33491965901

    Recruiting

  • Hôpital Privé Clairval ( Site 2549)

    Marseille, Bouches-du-Rhone, 13273

    Study Coordinator, +33496196234

    Recruiting

  • CHU La Timone ( Site 2508)

    Marseille, Bouches-du-Rhone, 13385

    Study Coordinator, +33491388801

    Recruiting

  • CHU Montpellier. ( Site 2556)

    Montpellier, Herault, 34295

    Study Coordinator, +33467336933

    Recruiting

  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 2539)

    Nice, Alpes-Maritimes, 06200

    Study Coordinator, +33492036667

    Recruiting

  • Hopital Cochin ( Site 2509)

    Paris, 75006

    Study Coordinator, +33158411781

    Recruiting

  • Hopital Saint Louis ( Site 2510)

    Paris, 75010

    Study Coordinator, +33142494949

    Recruiting

  • CHU Hopital Saint Antoine ( Site 2517)

    Paris, 75012

    Study Coordinator, +33171970387

    Recruiting

  • Groupe Hospitalier Diaconesses Croix Saint Simon ( Site 2545)

    Paris, 75020

    Study Coordinator, +33 1 44 74 11 53

    Recruiting

  • Hôpital Tenon ( Site 2530)

    Paris, 75020

    Study Coordinator, +33156016531

    Recruiting

  • Groupe hospitalier Paris saint Joseph-Service de Pneumologie-Allergologie -Oncologie Thoracique ( Site 2533)

    Paris, Île-de-France Region, 75014

    Study Coordinator, +33144123752

    Recruiting

  • Centre Hospitalier de Pau ( Site 2563)

    Pau, Pyrenees-Atlantiques, 64000

    Study Coordinator, +33559924723

    Recruiting

  • CHU Bordeaux Haut-Leveque ( Site 2534)

    Pessac, Aquitaine, 33600

    Completed

  • CH Lyon Sud Hospices Civils de Lyon ( Site 2521)

    Pierre-Bénite, Auvergne-Rhône-Alpes, 69495

    Study Coordinator, +33478861679

    Recruiting

  • C.H.U. Pontchaillou ( Site 2511)

    Pierre-Bénite, Rhone, 35033

    Study Coordinator, +33299289795

    Recruiting

  • Centre Hospitalier Universitaire de Poitiers-Dermatologie ( Site 2544)

    Poitiers, Vienne, 86021

    Study Coordinator, 0549444444

    Recruiting

  • Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 2525)

    Rennes, Ille-et-Vilaine, 35042

    Study Coordinator, 33299253196

    Recruiting

  • Centre Henri Becquerel ( Site 2547)

    Rouen, Seine-Maritime, 76038

    Study Coordinator, +33232082222

    Recruiting

  • Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes-lung oncology ( Site 2546)

    Saint-Herblain, Loire-Atlantique, 44800

    Study Coordinator, +33240083333

    Recruiting

  • Institut de Cancérologie de l'Ouest-Oncologie Médicale ( Site 2522)

    Saint-Herblain, Loire-Atlantique, 44805

    Study Coordinator, +33240679900

    Recruiting

  • Nouvel Hôpital Civil (NHC) ( Site 2529)

    Strasbourg, Alsace, 67091

    Study Coordinator, +33369550905

    Recruiting

  • Hôpital Foch ( Site 2543)

    Suresnes, Hauts-de-Seine, 92150

    Study Coordinator, +33146252078

    Recruiting

  • CHU Toulouse - Hopital Rangueil ( Site 2518)

    Toulouse, Haute-Garonne, 31059

    Study Coordinator, +33561322142

    Recruiting

  • Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE ( Site 2560)

    Toulouse, Haute-Garonne, 31059

    Study Coordinator, +33531156191

    Recruiting

  • CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 2526)

    Toulouse, Haute-Garonne, 31400

    Active, not recruiting

  • C.H.U. de Tours - Hopital Bretonneau ( Site 2515)

    Tours, Indre-et-Loire, 37044

    Study Coordinator, +33247474747

    Recruiting

  • Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 2532)

    Vandœuvre-lès-Nancy, Lorraine, 54519

    Study Coordinator, +33383598461

    Recruiting

  • Hôpital Universitaire Paul Brousse ( Site 2541)

    Villejuif, Val-de-Marne, 94800

    Study Coordinator, +33145596540

    Recruiting

  • Institut Gustave Roussy ( Site 2513)

    Villejuif, Île-de-France Region, 94800

    Study Coordinator, +33142114210

    Recruiting

Other trials in France

Spain41 sites, 30 recruiting

  • Hospital General Universitario de Alicante-Oncologia ( Site 0881)

    Alicante, 03010

    Active, not recruiting

  • Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 0851)

    Badalona, Catalonia, 08916

    Study Coordinator, +34934978925

    Recruiting

  • Hospital Clinic de Barcelona ( Site 0852)

    Barcelona, Catalonia, 08036

    Study Coordinator, +34932275402

    Recruiting

  • Hospital de la Santa Creu i Sant Pau-Oncología Médica ( Site 0862)

    Barcelona, Catalonia, 08041

    Completed

  • Parc de Salut Mar - Hospital del Mar-Oncologia ( Site 0873)

    Barcelona, 08003

    Study Coordinator, +34932483860

    Recruiting

  • H.U. Vall de Hebron ( Site 0850)

    Barcelona, 08035

    Study Coordinator, +34934894158

    Recruiting

  • Hospital Vall d´Hebron Skin Cancer & Woman cancer therapeutic area ( Site 0887)

    Barcelona, 08035

    Study Coordinator, +34 93 274 60 00

    Recruiting

  • Vall d´Hebron Gastric & Esophageal & Colorectal cancer therapeutic area ( Site 0889)

    Barcelona, 08035

    Study Coordinator, +34 93 274 60 00

    Recruiting

  • Vall d´Hebron Prostatic & Renal & Bladder cancer therapeutic area ( Site 0888)

    Barcelona, 08035

    Study Coordinator, +34 93 274 60 00

    Recruiting

  • Hospital Universitario Reina Sofia ( Site 0885)

    Córdoba, 14004

    Study Coordinator, +34 957011456

    Recruiting

  • Complejo Hospitalario de Jaén-Servicio de Oncología Médica ( Site 0879)

    Jaén, 23007

    Study Coordinator, +34953220306

    Recruiting

  • Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0860)

    L'Hospitalet de Llobregat, Barcelona, 08907

    Study Coordinator, +34932607744

    Recruiting

  • Hospital Universitario Insular de Gran Canaria ( Site 0867)

    Las Palmas de Gran Canaria, Las Palmas, 35001

    Study Coordinator, +34961452191

    Recruiting

  • Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 0877)

    Madrid, Madrid, Comunidad de, 28034

    Study Coordinator, +34913368263

    Recruiting

  • Hospital Universitario Gregorio Maranon ( Site 0864)

    Madrid, 28009

    Study Coordinator, +34914269393

    Recruiting

  • Clinica Universitaria de Navarra ( Site 0855)

    Madrid, 28027

    Study Coordinator, +34948255400

    Recruiting

  • Hospital Clinico San Carlos ( Site 0857)

    Madrid, 28040

    Study Coordinator, +34913303000ext7768

    Recruiting

  • Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0871)

    Madrid, 28040

    Study Coordinator, +34 91 550 48 00

    Recruiting

  • Hospital General Universitario 12 de Octubre ( Site 0856)

    Madrid, 28041

    Study Coordinator, +34914692313

    Recruiting

  • Hospital Universitario La Paz ( Site 0853)

    Madrid, 28046

    Active, not recruiting

  • Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0869)

    Madrid, 28050

    Study Coordinator, +34917567825

    Recruiting

  • Hospital Universitario Puerta de Hierro-Majadahonda ( Site 0861)

    Majadahonda, Madrid, 28222

    Study Coordinator, +34911917759

    Recruiting

  • H.R.U Malaga - Hospital General ( Site 0884)

    Málaga, Malaga, 29010

    Study Coordinator, +34 951308130

    Recruiting

  • Hospital Universitario Virgen de la Victoria ( Site 0878)

    Málaga, 29010

    Study Coordinator, +34951032508

    Recruiting

  • Hospital Universitario Central de Asturias-Medical Oncology ( Site 0870)

    Oviedo, Principality of Asturias, 33011

    Study Coordinator, 34 985108000 x36582

    Recruiting

  • Hospital Universitari Son Espases-Oncologia ( Site 0883)

    Palma, Balearic Islands, 07120

    Completed

  • Hospital Son Llatzer ( Site 0886)

    Palma de Mallorca, Balearic Islands, 07198

    Completed

  • Hospital Universitario Quiron Madrid ( Site 0868)

    Pozuelo de Alarcón, Madrid, 28223

    Completed

  • Hospital Universitari Sant Joan de Reus-Oncology ( Site 0874)

    Reus, Tarragona, 43204

    Study Coordinator, +34977310300

    Recruiting

  • Hospital Universitario de Donostia ( Site 0890)

    San Sebastian- Donostia, Basque Country, 20014

    Study Coordinator, +34943328338

    Recruiting

  • H. Marques de Valdecilla ( Site 0865)

    Santander, Cantabria, 39008

    Study Coordinator, +34942202525

    Recruiting

  • CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0876)

    Santiago de Compostela, La Coruna, 15706

    Completed

  • Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 0880)

    Seville, 41009

    Study Coordinator, +34 671560092

    Recruiting

  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 0872)

    Seville, 41013

    Study Coordinator, +34915504800

    Recruiting

  • Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 0882)

    Seville, 41014

    Study Coordinator, 34 955015273

    Recruiting

  • Hospital Universitari i Politecnic La Fe ( Site 0875)

    Valencia, Valencia, 46026

    Completed

  • Instituto Valenciano de Oncologia - IVO ( Site 0863)

    Valencia, Valenciana, Comunitat, 46009

    Study Coordinator, +34961114605

    Recruiting

  • Hospital Clinico de Valencia ( Site 0858)

    Valencia, Valenciana, Comunitat, 46010

    Completed

  • Hospital General Universitario de Valencia ( Site 0854)

    Valencia, Valenciana, Comunitat, 46014

    Completed

  • Hospital Arnau de Vilanova ( Site 0866)

    Valencia, Valenciana, Comunitat, 46015

    Completed

  • Hospital Clinico Universitario Lozano Blesa ( Site 0859)

    Zaragoza, 50009

    Study Coordinator, +34976765746

    Recruiting

Other trials in Spain

Russia37 sites, 1 recruiting

  • Altai Regional Clinical Oncology Center ( Site 1229)

    Barnaul, Altayskiy Kray, 656045

    Active, not recruiting

  • Belgorod Oncology Dispensary ( Site 1213)

    Belgorod, Belgorod Oblast, 308010

    Active, not recruiting

  • LLC Medical Centre "Lotos" ( Site 1253)

    Chelyabinsk, Chelyabinsk Oblast, 454080

    Completed

  • Regional Budgetary Healthcare Institution 'Ivanovo Regional Oncology Dispensary'-Urology ( Site 1219)

    Ivanovo, Ivanovo Oblast, 153040

    Active, not recruiting

  • Udmurtian Republican Clinical Oncology Center ( Site 1212)

    Izhevsk, Udmurtiya Republic, 426009

    Completed

  • Republican Clinical Oncology Dispensary ( Site 1228)

    Kazan', Tatarstan, Respublika, 420029

    Active, not recruiting

  • Republican Clinical Oncology Dispensary of Tatarstan MoH named after professor M.Z. Sigal ( Site 1203)

    Kazan', Tatarstan, Respublika, 420029

    Completed

  • The National Medico-Surgical Center N.I. Pirogov ( Site 1225)

    Moscow, Moscow, 105203

    Completed

  • N.N. Blokhin NMRCO ( Site 1209)

    Moscow, Moscow, 115478

    Completed

  • Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1201)

    Moscow, Moscow, 115478

    Completed

  • FSBI-FRCC of Special Types Med. Care and Technologies FMBA of Russia ( Site 1234)

    Moscow, Moscow, 115682

    Active, not recruiting

  • Russian Scientific Center of Roentgenoradiology ( Site 1215)

    Moscow, Moscow, 117485

    Active, not recruiting

  • First Moscow State Medical University n.a. I.M.Sechenov ( Site 1245)

    Moscow, Moscow, 119991

    Active, not recruiting

  • P. A. Hertsen Moscow Oncology Research Center ( Site 1214)

    Moscow, Moscow, 125284

    Completed

  • P. A. Hertsen Moscow Oncology Research Center ( Site 1247)

    Moscow, Moscow, 125284

    Active, not recruiting

  • FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 1208)

    Moscow, Moscow, 125367

    Completed

  • Volga District Medical Center Federal Medical and Biological Agency ( Site 1242)

    Nizhny Novgorod, Nizhny Novgorod Oblast, 603074

    Active, not recruiting

  • GBUZ SK Pyatigorsk Interdistrict Oncology dispensary ( Site 1223)

    Pyatigorsk, Stavropol Kray, 357502

    Completed

  • Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 1224)

    Saint Petersburg, Sankt-Peterburg, 191024

    Completed

  • St. Petersburg Clinical Hospital of Russian Academy Of Sciences ( Site 1235)

    Saint Petersburg, Sankt-Peterburg, 194017

    Completed

  • EuroCityClinic ( Site 1230)

    Saint Petersburg, Sankt-Peterburg, 197022

    Completed

  • First Pavlov State Medical University of Saint Petersburg ( Site 1232)

    Saint Petersburg, Sankt-Peterburg, 197022

    Active, not recruiting

  • Almazov National Medical Research Centre ( Site 1233)

    Saint Petersburg, Sankt-Peterburg, 197341

    Completed

  • Clinical Research Center of specialized types medical care-Oncology ( Site 1205)

    Saint Petersburg, Sankt-Peterburg, 197758

    Active, not recruiting

  • N.N.Petrov Research Institute of Oncology-Department of Preclinical and Clinical Research ( Site 1211)

    Saint Petersburg, Sankt-Peterburg, 197758

    Completed

  • National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1210)

    Saint Petersburg, Sankt-Peterburg, 197758

    Active, not recruiting

  • City Clinical Oncology Center ( Site 1237)

    Saint Petersburg, Sankt-Peterburg, 198255

    Study Coordinator, +79675231217

    Recruiting

  • GBUZ LOKB ( Site 1218)

    Saint-Petersburg, Leningradskaya Oblast', 194291

    Completed

  • GBUZ LOKB-Oncology department #1 ( Site 1222)

    Saint-Petersburg, Leningradskaya Oblast', 194291

    Active, not recruiting

  • Ogarev Mordovia State University ( Site 1206)

    Saransk, Mordoviya, Respublika, 430005

    Completed

  • Oncological Dispensary #2 of Ministry of Health of Krasnodar region ( Site 1244)

    Sochi, Krasnodarskiy Kray, 354057

    Active, not recruiting

  • Tomsk Scientific Research Institute of Oncology ( Site 1227)

    Tomsk, Tomsk Oblast, 634028

    Completed

  • SAIH of the Tyumen region, Multidisciplinary Clinical Medical Center "Medical town" ( Site 1220)

    Tyumen, Tyumen Oblast, 625000

    Active, not recruiting

  • GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1250)

    Ufa, Baskortostan, Respublika, 450054

    Completed

  • Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1204)

    Ufa, Baskortostan, Respublika, 450054

    Active, not recruiting

  • Bashkir State Medical University ( Site 1221)

    Ufa, Baskortostan, Respublika, 450083

    Completed

  • Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1243)

    Yaroslavl, Yaroslavl Oblast, 150054

    Active, not recruiting

Other trials in Russia

Turkey (Türkiye)31 sites, 26 recruiting

  • Acibadem Adana Hospital-Pediatric Hematology-Oncology ( Site 1312)

    Adana, 01130

    Study Coordinator, +905349179166

    Recruiting

  • Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1307)

    Adana, 01250

    Study Coordinator, +903223272727

    Recruiting

  • Adana Sehir Egitim ve Arastirma Hastanesi ( Site 1324)

    Adana, 01370

    Study Coordinator, +90 322 455 90 00

    Recruiting

  • Ankara University Hospital Cebeci ( Site 1306)

    Ankara, 06100

    Study Coordinator, +903125957115

    Recruiting

  • Hacettepe Universitesi-oncology hospital ( Site 1304)

    Ankara, 06230

    Study Coordinator, +905334318506

    Recruiting

  • Gazi University Health Research and Application Center Gazi Hospital ( Site 1325)

    Ankara, 06560

    Study Coordinator, 03122026970

    Recruiting

  • Ankara University Health Practice and Research Hospitals ( Site 1331)

    Ankara, 06620

    Study Coordinator, 00903124663550

    Recruiting

  • Liv Hospital Ankara ( Site 1330)

    Ankara, 06680

    Study Coordinator, 444 6 623

    Recruiting

  • Ankara City Hospital-Medical Oncology ( Site 1311)

    Ankara, 06800

    Study Coordinator, +905551737206

    Recruiting

  • Baskent Universitesi Ankara Hastanesi ( Site 1303)

    Ankara, 34180

    Study Coordinator, 905333414050

    Recruiting

  • Akdeniz Universitesi Hastanesi-Medical Onkology ( Site 1318)

    Antalya, 07059

    Study Coordinator, 90 (242) 249 60 00

    Recruiting

  • Memorial Antalya Hospital-Oncology ( Site 1315)

    Antalya, 07090

    Active, not recruiting

  • Dokuz Eylul Universitesi Hastanesi ( Site 1323)

    Balçova, İzmir, 35340

    Study Coordinator, +902324129898

    Recruiting

  • Trakya Universitesi Tip Fakultesi ( Site 1301)

    Edirne, 22030

    Study Coordinator, +902842360910

    Recruiting

  • Atatürk Üniversitesi ( Site 1333)

    Erzurum, 25240

    Study Coordinator, +90 442 344 66 66

    Recruiting

  • Bezmialem Vakf Üniversitesi-Oncology ( Site 1308)

    Istanbul, 34093

    Study Coordinator, 444 0 600

    Recruiting

  • Istanbul University Capa Campus ( Site 1314)

    Istanbul, 34093

    Active, not recruiting

  • Medipol Mega Universite Hastanesi ( Site 1326)

    Istanbul, 34214

    Study Coordinator, +90212447244

    Recruiting

  • Acibadem Universitesi Atakent Hastanesi ( Site 1319)

    Istanbul, 34303

    Completed

  • Acıbadem Maslak Hastanesi-Medical Oncology ( Site 1321)

    Istanbul, 34457

    Study Coordinator, +902123034813

    Recruiting

  • Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1302)

    Istanbul, 34668

    Study Coordinator, +902124143434

    Recruiting

  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1316)

    Istanbul, 34722

    Study Coordinator, +905063509061

    Recruiting

  • Umraniye Training and Research Hospital ( Site 1329)

    Istanbul, 34766

    Study Coordinator, 0216 632 1818

    Recruiting

  • Marmara Universitesi Pendik Egitim Arastirma Hastanesi-Medical Oncology ( Site 1305)

    Istanbul, 34899

    Study Coordinator, +905323702473

    Recruiting

  • Ege Universitesi Tip Fakultesi Hastanesi ( Site 1300)

    Izmir, 35040

    Study Coordinator, 905337360674

    Recruiting

  • I.E.U. Medical Point Hastanesi-Oncology ( Site 1310)

    Izmir, 35577

    Active, not recruiting

  • Kocaeli Üniversitesi ( Site 1313)

    Kocaeli, 41380

    Study Coordinator, +902623037575

    Recruiting

  • Inonu Universitesi ( Site 1309)

    Malatya, 44280

    Study Coordinator, +905385003562

    Recruiting

  • Sakarya University School of Medicine ( Site 1332)

    Sakarya, 54100

    Study Coordinator, +0902648884000

    Recruiting

  • Samsun Medical Park Hastanesi ( Site 1328)

    Samsun, 55200

    Study Coordinator, +9 0 362 311 40 40

    Recruiting

  • Acibadem Altunizade Hospital-Oncology ( Site 1317)

    Üsküdar /Istanbul, Istanbul

    Active, not recruiting

Other trials in Turkey (Türkiye)

Australia30 sites, 19 recruiting

  • Royal Adelaide Hospital ( Site 3014)

    Adelaide, South Australia, 5000

    Study Coordinator, +61870740000

    Recruiting

  • Mater Misericordiae Limited-Medical Oncology ( Site 3019)

    Brisbane, Queensland, 4101

    Completed

  • Gallipoli Medical Research Ltd ( Site 3011)

    Brisbane, Queensland, 4120

    Completed

  • Chris OBrien Lifehouse ( Site 3003)

    Camperdown, New South Wales, 2050

    Active, not recruiting

  • Royal Prince Alfred Hospital-A.W. Morrow Gastroenterology and Liver Centre ( Site 3016)

    Camperdown, New South Wales, 2050

    Completed

  • Monash Health ( Site 3015)

    Clayton, Victoria, 3168

    Study Coordinator, +61438780439

    Recruiting

  • Austin Health-Austin Hospital ( Site 3004)

    Heidelberg, Victoria, 3084

    Study Coordinator, +61385598872

    Recruiting

  • Royal Brisbane and Women's Hospital ( Site 3009)

    Herston, Queensland, 4029

    Active, not recruiting

  • Liverpool Hospital-Medical Oncology ( Site 3021)

    Liverpool, New South Wales, 2170

    Study Coordinator, +61287389000

    Recruiting

  • Macquarie University ( Site 3010)

    Macquarie University, New South Wales, 2109

    Study Coordinator, +61298123635

    Recruiting

  • Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 3008)

    Melbourne, Victoria, 3000

    Study Coordinator, +61396563642

    Recruiting

  • St Vincent's Hospital-Oncology Clinical Trials ( Site 3018)

    Melbourne, Victoria, 3065

    Study Coordinator, 61392313167

    Recruiting

  • Fiona Stanley Hospital ( Site 3029)

    Murdock, Western Australia, 6150

    Study Coordinator, 61861526712

    Recruiting

  • Sir Charles Gairdner Hospital ( Site 3006)

    Nedlands, Western Australia, 6009

    Study Coordinator, +61864573333

    Recruiting

  • Mater Hospital Sydney ( Site 3007)

    North Sydney, New South Wales, 2060

    Active, not recruiting

  • Orange Hospital-Clinical Trials Unit ( Site 3027)

    Orange, New South Wales, 2800

    Study Coordinator, 61263693000

    Recruiting

  • Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3020)

    Port Macquarie, New South Wales, 2444

    Study Coordinator, 0439 345 715

    Recruiting

  • Gold Coast University Hospital ( Site 3028)

    Southport, Queensland, 4215

    Study Coordinator, +611300744284

    Recruiting

  • Tasman Oncology Research Pty Ltd ( Site 3012)

    Southport, Queensland, 4215

    Study Coordinator, +61756132480

    Recruiting

  • Western Health-Sunshine & Footscray Hospitals ( Site 3023)

    St Albans, Victoria, 3021

    Study Coordinator, 61383451333

    Recruiting

  • Royal North Shore Hospital-Medical Oncology Clinical Trials ( Site 3025)

    St Leonards, New South Wales, 2065

    Study Coordinator, +61294631172

    Recruiting

  • St John of God Subiaco Hospital ( Site 3013)

    Subiaco, Western Australia, 6008

    Active, not recruiting

  • Sunshine Coast University Private Hospital-Coastal Cancer Care ( Site 3032)

    Sunshine Coast, Queensland, 4575

    Active, not recruiting

  • The Townsville Hospital ( Site 3017)

    Townsville, Queensland, 4814

    Active, not recruiting

  • Calvary Mater Newcastle ( Site 3005)

    Waratah, New South Wales, 2298

    Active, not recruiting

  • Ballarat Oncology & Haematology Services ( Site 3022)

    Wendouree, Victoria, 3355

    Study Coordinator, 61353398000

    Recruiting

  • Westmead Hospital ( Site 3000)

    Westmead, New South Wales, 2145

    Study Coordinator, +61298459553

    Recruiting

  • Melanoma Institute Australia ( Site 3001)

    Wollstonecraft, New South Wales, 2065

    Study Coordinator, +61299117321

    Recruiting

  • The Queen Elizabeth Hospital ( Site 3026)

    Woodville, South Australia, 5011

    Study Coordinator, +61 8 82227096

    Recruiting

  • Princess Alexandra Hospital ( Site 3002)

    Woolloongabba, Queensland, 4102

    Active, not recruiting

Other trials in Australia

Brazil28 sites, 23 recruiting

  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1010)

    Barretos, São Paulo, 14784400

    Study Coordinator, +551733216637

    Recruiting

  • Hospital Tacchini ( Site 1040)

    Bento Gonçalves, Rio Grande do Sul, 95700-000

    Study Coordinator, +555434554333

    Recruiting

  • Hospital Erasto Gaertner ( Site 1036)

    Curitiba, Paraná, 81520-060

    Active, not recruiting

  • CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 1034)

    Florianópolis, Santa Catarina, 88020-210

    Active, not recruiting

  • CEPON ( Site 1012)

    Florianópolis, Santa Catarina, 88034-000

    Study Coordinator, 5548984320757

    Recruiting

  • Hospital São Carlos-Oncocentro Ce ( Site 1029)

    Fortaleza, Ceará, 60135-237

    Study Coordinator, +558532865934

    Recruiting

  • CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 1024)

    Fortaleza, Ceará, 60336-232

    Study Coordinator, +55 85 32865934

    Recruiting

  • Centro de Pesquisa Clínica do Instituto do Câncer do Ceará ( Site 1016)

    Fortaleza, Ceará, 60430235

    Study Coordinator, +5585999547790

    Recruiting

  • ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 1008)

    Ijuí, Rio Grande do Sul, 98700-000

    Study Coordinator, +555531950504

    Recruiting

  • Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1041)

    Itajaí, Santa Catarina, 88301-220

    Active, not recruiting

  • Hospital Amaral Carvalho ( Site 1023)

    Jaú, São Paulo, 17210-080

    Study Coordinator, +551436021397

    Recruiting

  • Hospital de Clínicas de Passo Fundo ( Site 1025)

    Passo Fundo, Rio Grande do Sul, 99010-260

    Study Coordinator, +555421034130

    Recruiting

  • Lacks - Oncologia E Hematologia ( Site 1026)

    Pelotas, Rio Grande do Sul, 96020-080

    Study Coordinator, +555330285068

    Recruiting

  • Hospital de Clinicas de Porto Alegre ( Site 1000)

    Porto Alegre, Rio Grande do Sul, 90035-903

    Study Coordinator, +555133598619

    Recruiting

  • Hospital São Lucas da PUCRS-Centro de Pesquisa em Oncologia ( Site 1006)

    Porto Alegre, Rio Grande do Sul, 90610-000

    Study Coordinator, 555133203000

    Recruiting

  • Hospital Nossa Senhora da Conceição ( Site 1011)

    Porto Alegre, Rio Grande do Sul, 91350-200

    Study Coordinator, +555135160954

    Recruiting

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 1035)

    Porto Alegree, Rio Grande do Sul, 90050-170

    Active, not recruiting

  • Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 1020)

    Rio de Janeiro, 20230-130

    Study Coordinator, +552132076585

    Recruiting

  • Instituto de de Educação, pesquisa e Gestão em Saúde ( Site 1014)

    Rio de Janeiro, 22775-001

    Study Coordinator, +552135092115

    Recruiting

  • Clinica Viver ( Site 1021)

    Santa Maria, Rio Grande do Sul, 97015-372

    Study Coordinator, +55 55 30267720

    Recruiting

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site 1003)

    São José do Rio Preto, São Paulo, 15090000

    Study Coordinator, 551732015054

    Recruiting

  • Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA ( Site 1017)

    São Paulo, São Paulo, 01317-001

    Study Coordinator, 5511991931500

    Recruiting

  • Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 1001)

    São Paulo, 01246-000

    Study Coordinator, +551138932645

    Recruiting

  • BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 1030)

    São Paulo, 01321-001

    Study Coordinator, +551135056675

    Recruiting

  • Hospital Paulistano ( Site 1033)

    São Paulo, 01321-001

    Study Coordinator, +551131411083

    Recruiting

  • A. C. Camargo Cancer Center ( Site 1002)

    São Paulo, 01509-010

    Study Coordinator, 551121895000

    Recruiting

  • Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 1018)

    São Paulo, 04014-012

    Study Coordinator, 55 11 4450-0363

    Recruiting

  • Instituto de Oncologia Saint Gallen ( Site 1039)

    Ssanta Cruz Do Sul, Rio Grande do Sul, 96810-102

    Active, not recruiting

Other trials in Brazil

Italy26 sites, 14 recruiting

  • IRCCS CRO Aviano, Hematology/Oncology ( Site 1957)

    Aviano, Pordenone, 33081

    Completed

  • Humanitas Gavazzeni ( Site 1954)

    Bergamo, 24125

    Completed

  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII-UOC Oncologia ( Site 1967)

    Bergamo, 24127

    Study Coordinator, +390352673694

    Recruiting

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1978)

    Bologna, Emilia-Romagna, 40138

    Study Coordinator, +39 0512144548

    Recruiting

  • Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1972)

    Brescia, 25123

    Completed

  • INOC - Istituto Nazionale Oncologico Candiolo ( Site 1960)

    Candiolo, Torino, 10060

    Active, not recruiting

  • Ospedale Cannizzaro ( Site 1981)

    Catania, Sicily, 95126

    Completed

  • IRCCS A.O.U. San Martino - IST ( Site 1961)

    Genova, 16132

    Completed

  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1977)

    Milan, Lombardy, 20133

    Study Coordinator, 0223903650

    Recruiting

  • Ospedale San Raffaele. ( Site 1979)

    Milan, 20132

    Study Coordinator, 02 26438003

    Recruiting

  • Istituto Europeo di Oncologia ( Site 1952)

    Milan, 20141

    Study Coordinator, +390294372161

    Recruiting

  • Azienda Ospedaliera San Gerardo ( Site 1980)

    Monza, Lombardy, 20900

    Active, not recruiting

  • Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1955)

    Naples, 80131

    Active, not recruiting

  • Ospedale San Luigi Gonzaga ( Site 1956)

    Orbassano, Torino, 10143

    Active, not recruiting

  • Istituto Oncologico Veneto IRCCS ( Site 1976)

    Padova, Veneto, 35128

    Study Coordinator, +39 049 8215931

    Recruiting

  • Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 1964)

    Parma, 43126

    Study Coordinator, 390521702682

    Recruiting

  • Fondazione IRCCS Policlinico San Matteo ( Site 1982)

    Pavia, 27100

    Study Coordinator, 0382.502511

    Recruiting

  • AO Santa Maria della Misericordia-Oncology Department ( Site 1971)

    Perugia, Umbria, 06132

    Completed

  • Azienda Ospedaliera San Camillo Forlanini ( Site 1958)

    Roma, 00152

    Completed

  • Policlinico Universitario Agostino Gemelli ( Site 1965)

    Roma, 00168

    Study Coordinator, +390630155878

    Recruiting

  • Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 1963)

    Rome, Lazio, 00144

    Study Coordinator, +390652665637

    Recruiting

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1975)

    Rome, Lazio, 00168

    Study Coordinator, +39 06 3015 5202

    Recruiting

  • Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1968)

    Rozzano, Milano, 20089

    Study Coordinator, 390282244080

    Recruiting

  • ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 1969)

    Siena, 53100

    Study Coordinator, +390577586335

    Recruiting

  • Azienda Ospedaliera Santa Maria ( Site 1962)

    Terni, 05100

    Study Coordinator, +390744205410

    Recruiting

  • Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 1974)

    Torino, 10126

    Completed

Other trials in Italy

South Korea22 sites, 9 recruiting

  • Chungbuk National University Hospital ( Site 0961)

    Cheongju-si, North Chungcheong, 28644

    Active, not recruiting

  • Keimyung University Dongsan Hospital CRC room 1 ( Site 0960)

    Daegu, Taegu-Kwangyokshi, 42601

    Active, not recruiting

  • Chungnam national university hospital-Department of Internal Medicine ( Site 0958)

    Daejeon, Taejon-Kwangyokshi, 35015

    Active, not recruiting

  • Kyungpook National University Chilgok Hospital ( Site 0964)

    Deagu, Taegu-Kwangyokshi, 41404

    Active, not recruiting

  • Gangnam Severance Hospital, Yonsei University Health System ( Site 0966)

    Gangnam-gu, Seoul, 06273

    Completed

  • National Cancer Center ( Site 0955)

    Goyang-si, Kyonggi-do, 10408

    Active, not recruiting

  • Chonnam National University Hwasun Hospital-Hemato-Oncology ( Site 0959)

    Hwasun, Jeonranamdo, 58128

    Active, not recruiting

  • Gachon University Gil Medical Center ( Site 0967)

    Inceon, Incheon, 21565

    Completed

  • CHA Bundang Medical Center CHA University ( Site 0957)

    Seongnam-si, Kyonggi-do, 13496

    Active, not recruiting

  • Seoul National University Bundang Hospital ( Site 0951)

    Seongnam-si, Kyonggi-do, 13620

    Study Coordinator, +82215883369

    Recruiting

  • Korea University Anam Hospital ( Site 0956)

    Seoul, 02841

    Active, not recruiting

  • Seoul National University Hospital ( Site 0953)

    Seoul, 03080

    Study Coordinator, +82220720850

    Recruiting

  • Severance Hospital ( Site 0954)

    Seoul, 03722

    Study Coordinator, +82222288130

    Recruiting

  • Severance Hospital, Yonsei University Health System ( Site 0962)

    Seoul, 03722

    Study Coordinator, +82-2-2228-4190

    Recruiting

  • Samsung Medical Center ( Site 0950)

    Seoul, 06351

    Study Coordinator, 82234103438

    Recruiting

  • Samsung Medical Center ( Site 0970)

    Seoul, 06351

    Study Coordinator, +821020154932

    Recruiting

  • Samsung Medical Center ( Site 0971)

    Seoul, 06351

    Study Coordinator, +82234106250

    Recruiting

  • The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 0972)

    Seoul, 06591

    Completed

  • Korea University Guro Hospital ( Site 0963)

    Seoul, 08308

    Active, not recruiting

  • Asan Medical Center ( Site 0952)

    Songpagu, Seoul, 05505

    Study Coordinator, +82216887575

    Recruiting

  • The Catholic University Of Korea St. Vincent's Hospital ( Site 0968)

    Suwon, Kyonggi-do, 16247

    Study Coordinator, +82312498153

    Recruiting

  • Ajou University Hospital ( Site 0969)

    Suwon, Kyonggi-do, 16499

    Active, not recruiting

Other trials in South Korea

Argentina21 sites, 11 recruiting

  • Centro de Oncología e Investigación de Buenos Aires ( Site 1357)

    Berazategui, Buenos Aires, B1884BBF

    Active, not recruiting

  • Hospital Aleman-Oncology ( Site 1351)

    Buenos Aires, C1118AAT

    Active, not recruiting

  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 1368)

    Buenos Aires., Buenos Aires, C1431FWO

    Completed

  • Fundacion Favaloro ( Site 1367)

    CABA, Buenos Aires, C1093AAS

    Completed

  • Derma Internacional SA ( Site 1372)

    CABA, Buenos Aires, C1426ECQ

    Study Coordinator, 01168192023

    Recruiting

  • Instituto Alexander Fleming ( Site 1364)

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ

    Study Coordinator, +54-911-36115955

    Recruiting

  • IDIM - Instituto de Investigaciones Metabólicas ( Site 1362)

    Ciudad de Buenos Aires, Buenos Aires, C1012AAR

    Completed

  • Clínica Universitaria Reina Fabiola ( Site 1376)

    Córdoba, X5004SHP

    Study Coordinator, +5435196778868

    Recruiting

  • Centro Medico Privado CEMAIC ( Site 1371)

    Córdoba, X5008AAC

    Study Coordinator, +5493513976568

    Recruiting

  • Hospital Privado Universitario de Córdoba ( Site 1354)

    Córdoba, X5016KEH

    Completed

  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 1358)

    La Rioja, F5300COE

    Study Coordinator, +54-380-443-6443

    Recruiting

  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 1363)

    Mar del Plata, Buenos Aires, B7600FYZ

    Study Coordinator, +54-911-36115955

    Recruiting

  • Instituto Médico Río Cuarto ( Site 1375)

    Río Cuarto, Córdoba Province, X5800

    Study Coordinator, +5493585628491

    Recruiting

  • Fundacion Estudios Clinicos ( Site 1369)

    Rosario, Santa Fe Province, S2000CEJ

    Study Coordinator, +543412384171

    Recruiting

  • Sanatorio Parque ( Site 1355)

    Rosario, Santa Fe Province, S2000DSV

    Study Coordinator, 543414268409

    Recruiting

  • Instituto de Oncologia de Rosario ( Site 1350)

    Rosario, Santa Fe Province, S2000KZE

    Study Coordinator, 5493415778394

    Recruiting

  • Hospital Provincial del Centenario ( Site 1359)

    Rosario, Santa Fe Province, S2002KDS

    Active, not recruiting

  • Instituto San Marcos ( Site 1366)

    San Juan, J5400EBB

    Active, not recruiting

  • Centro Medico San Roque-Oncology ( Site 1352)

    San Miguel de Tucumán, T4000IAK

    Active, not recruiting

  • Centro Oncologico Norte. ( Site 1370)

    Santiago del Estero, G4200AWD

    Study Coordinator, +543854754816

    Recruiting

  • Clinica Viedma ( Site 1353)

    Viedma, Río Negro Province, R8500ACE

    Completed

Other trials in Argentina

Poland21 sites, 20 recruiting

  • Bialostockie Centrum Onkologii ( Site 1610)

    Bialystok, Podlaskie Voivodeship, 15-027

    Study Coordinator, +48692267220

    Recruiting

  • Powiatowe Centrum Zdrowia w Brzezinach Sp. z o. o. Oddział Dziennej Chemioterapii ( Site 1611)

    Brzeziny, Łódź Voivodeship, 95-060

    Completed

  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 1612)

    Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796

    Study Coordinator, +48523743589

    Recruiting

  • Uniwersyteckie Centrum Kliniczne-Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej ( Site 1622)

    Gdansk, Pomeranian Voivodeship, 80-214

    Study Coordinator, 58 584 44 66

    Recruiting

  • Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1625)

    Gdynia, Pomeranian Voivodeship, 81-519

    Study Coordinator, +48583419348

    Recruiting

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1620)

    Gliwice, Silesian Voivodeship, 44-102

    Study Coordinator, 32 278 97 94

    Recruiting

  • Przychodnia Lekarska KOMED ( Site 1603)

    Konin, Greater Poland Voivodeship, 62-500

    Study Coordinator, 48632428009

    Recruiting

  • Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie ( Site 1614)

    Koszalin, West Pomeranian Voivodeship, 75-581

    Study Coordinator, +48502204953

    Recruiting

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 1608)

    Krakow, Lesser Poland Voivodeship, 31-115

    Study Coordinator, +48126348245

    Recruiting

  • Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1618)

    Krakow, Lesser Poland Voivodeship, 31-826

    Study Coordinator, +48 126468000

    Recruiting

  • Instytut Centrum Zdrowia Matki Polki-Klinika Onkologii ( Site 1609)

    Lodz, Łódź Voivodeship, 93-338

    Study Coordinator, +48422711000

    Recruiting

  • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1623)

    Olsztyn, Warmian-Masurian Voivodeship, 10-357

    Study Coordinator, +48895322978

    Recruiting

  • Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Kosza-Klinika Onkologii z Odcinkiem Dziennym ( Site 1616)

    Opole, Opole Voivodeship, 45-061

    Study Coordinator, +48774416084

    Recruiting

  • Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 1607)

    Poznan, Greater Poland Voivodeship, 60-569

    Study Coordinator, 48618549038

    Recruiting

  • Med-Polonia Sp. z o. o. ( Site 1605)

    Poznan, Greater Poland Voivodeship, 60-693

    Study Coordinator, 505758992

    Recruiting

  • Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna ( Site 1601)

    Poznan, Greater Poland Voivodeship, 61-848

    Study Coordinator, +48618549014

    Recruiting

  • Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 1619)

    Poznan, Greater Poland Voivodeship, 61-866

    Study Coordinator, +48 61 88 50 738

    Recruiting

  • Szpital Rejonowy im. dr. J. Rostka w Raciborzu ( Site 1624)

    Racibórz, Silesian Voivodeship, 47-400

    Study Coordinator, +48327555006

    Recruiting

  • Luxmed Onkologia sp. z o. o. ( Site 1621)

    Warsaw, Masovian Voivodeship, 01-748

    Study Coordinator, +48224698363

    Recruiting

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 1604)

    Warsaw, Masovian Voivodeship, 02-781

    Study Coordinator, 48225463066

    Recruiting

  • Wojskowy Instytut Medyczny-Klinika Onkologii ( Site 1606)

    Warsaw, Masovian Voivodeship, 04-141

    Study Coordinator, +48226817235

    Recruiting

Other trials in Poland

Ukraine21 sites, 3 recruiting

  • COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 3671)

    Cherkasy, Cherkasy Oblast, 18009

    Active, not recruiting

  • ME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 3668)

    Dnipro, Dnipropetrovsk Oblast, 49005

    Active, not recruiting

  • Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council ( Site 3650)

    Dnipro, Dnipropetrovsk Oblast, 49102

    Active, not recruiting

  • Communal Non-Commercial Enterprise "Prykarpatski Clinical Oncological Center" of Ivano-Frankivsk Reg ( Site 3663)

    Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018

    Study Coordinator, +380502094000

    Recruiting

  • MNPE Regional Center of Oncology ( Site 3665)

    Kharkiv, Kharkiv Oblast, 61070

    Active, not recruiting

  • SO"Grigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine" ( Site 3666)

    Kharlkiv, Kharkiv Oblast, 61024

    Active, not recruiting

  • MNE "Khmelnytskyi regional antitumor center" ( Site 3675)

    Khmelnytskyi, Khmelnytskyi Oblast, 29009

    Active, not recruiting

  • Asklepion Medical Center ( Site 3667)

    Khodosovka, Kyivska Oblast, 08173

    Study Coordinator, 0503481865

    Recruiting

  • Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3656)

    Kropyvnytskyi, Kirovohrad Oblast, 25006

    Completed

  • MI Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional-Chemotherapy department ( Site 3657)

    Kryvyi Rih, Dnipropetrovsk Oblast, 50048

    Active, not recruiting

  • National Cancer Institute-Department of Minimally Invasive and Endoscopic Surgery, Interventional R ( Site 3658)

    Kyiv, Kyivska Oblast, 03022

    Active, not recruiting

  • LLC Clinic Verum Expert ( Site 3669)

    Kyiv, Kyivska Oblast, 03039

    Active, not recruiting

  • Municipal non-profit enterprise "Kyiv City Clinical Oncology Center" of executive body of Kyiv City ( Site 3651)

    Kyiv, Kyivska Oblast, 03115

    Completed

  • Municipal institution of Lviv regional council Lviv Oncology-Chemotherapy ( Site 3653)

    Lviv, Lviv Oblast, 79031

    Active, not recruiting

  • Odessa Regional Oncology Center ( Site 3655)

    Odesa, Odesa Oblast, 65055

    Active, not recruiting

  • Sumy regional clinical oncological dispensary-Oncothoracic department ( Site 3661)

    Sumy, Sumska Oblast, 40022

    Completed

  • Transcarpathian Regional Clinical Oncology Center-Chemotherapy dept. ( Site 3652)

    Uzhhorod, Zakarpattia Oblast, 88000

    Completed

  • Uzhhorod City Multidisciplinary Clinical Hospital ( Site 3672)

    Uzhhorod, Zakarpattia Oblast, 88000

    Study Coordinator, +380312647211

    Recruiting

  • Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council" ( Site 3662)

    Vinnytsia, Vinnytsia Oblast, 21029

    Completed

  • Municipal non-profit enterprise "Zaporizhzhia regional clinical hospital" of Zaporizhzhia regional c ( Site 3664)

    Zaporizhzhya, Zaporizhzhia Oblast, 69600

    Completed

  • Zhytomyr Regional Oncology Center ( Site 3670)

    Zhytomyr, Zhytomyr Oblast, 10002

    Active, not recruiting

Other trials in Ukraine

Canada19 sites, 17 recruiting

  • Arthur J.E. Child Comprehensive Cancer Centre ( Site 2815)

    Calgary, Alberta, T2N 5G2

    Study Coordinator, (587) 231-6204

    Recruiting

  • Cross Cancer Institute ( Site 2804)

    Edmonton, Alberta, T6G 1Z2

    Study Coordinator, 7804328248

    Recruiting

  • Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre-Oncology ( Site 2809)

    Greenfield Park, Quebec, J4V 2H1

    Study Coordinator, 4504665000

    Recruiting

  • Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2801)

    Hamilton, Ontario, L8V 5C2

    Completed

  • Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2808)

    Kingston, Ontario, K7L 2V7

    Study Coordinator, 6135496666

    Recruiting

  • Centre Intégré de Santé et de Services Sociaux (CISSS) de La-Centre intégré de cancérologie de Lava ( Site 2810)

    Laval, Quebec, H7M 3L9

    Study Coordinator, 450-668-1010x23671

    Recruiting

  • London Health Sciences Centre ( Site 2806)

    London, Ontario, N6A 5W9

    Completed

  • Centre Hospitalier de l Universite de Montreal - CHUM ( Site 2807)

    Montreal, Quebec, H2X 3E4

    Study Coordinator, 5144127512

    Recruiting

  • Jewish General Hospital ( Site 2800)

    Montreal, Quebec, H3T 1E2

    Study Coordinator, 5143408222

    Recruiting

  • St. Marys Hospital Center ( Site 2820)

    Montreal, Quebec, H3T 1M5

    Study Coordinator, 514-345-3511x3378

    Recruiting

  • McGill University Health Centre ( Site 2818)

    Montreal, Quebec, H4A 3J1

    Study Coordinator, 5149341934

    Recruiting

  • The Ottawa Hospital - General Campus ( Site 2813)

    Ottawa, Ontario, K1H 8L6

    Study Coordinator, 613-737-7700x71985

    Recruiting

  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 2805)

    Québec, Quebec, G1J 1Z4

    Study Coordinator, 4185254444

    Recruiting

  • Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 2812)

    Sherbrooke, Quebec, J1H 5H4

    Study Coordinator, 8193461110X12848

    Recruiting

  • Sunnybrook Research Institute ( Site 2802)

    Toronto, Ontario, M4N 3M5

    Study Coordinator, 4164804616

    Recruiting

  • Mount Sinai Hospital ( Site 2811)

    Toronto, Ontario, M5G 1X5

    Study Coordinator, 416-586-5117

    Recruiting

  • Princess Margaret Cancer Centre ( Site 2803)

    Toronto, Ontario, M5G 2C4

    Study Coordinator, 4169462000

    Recruiting

  • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 2816)

    Trois-Rivières, Quebec, G8Z 3R9

    Study Coordinator, 8196973333x63238

    Recruiting

  • CancerCare Manitoba ( Site 2814)

    Winnipeg, Manitoba, R3E 0V9

    Study Coordinator, 204-787-2197

    Recruiting

Other trials in Canada

United Kingdom19 sites, 10 recruiting

  • Aberdeen Royal Infirmary-Department of Oncology ( Site 0521)

    Aberdeen, Aberdeen City, AB25 2ZN

    Active, not recruiting

  • Belfast City Hospital ( Site 0508)

    Belfast, Northern Ireland, BT9 7AB

    Completed

  • Mid Essex Hospitals Service Trust. Broomfield Hospital ( Site 0503)

    Broomfield, Essex, CM1 7ET

    Completed

  • Addenbrookes Hospital ( Site 0522)

    Cambridge, Cambridgeshire, CB2 2QQ

    Active, not recruiting

  • University Hospital Coventry & Warwickshire ( Site 0524)

    Coventry, CV2 2DX

    Active, not recruiting

  • Western General Hospital ( Site 0502)

    Edinburgh, Edinburgh, City of, EH4 2XU

    Study Coordinator, +441315371000

    Recruiting

  • The Beatson West of Scotland Cancer Centre ( Site 0506)

    Glasgow, Glasgow City, G12 0YN

    Study Coordinator, +441413017073

    Recruiting

  • St James University Hospital ( Site 0509)

    Leeds, LS9 7TF

    Study Coordinator, +441132068320

    Recruiting

  • Barts Health NHS Trust ( Site 0512)

    London, London, City of, EC1A 7BE

    Study Coordinator, +442034657108

    Recruiting

  • University College London Hospital-Cancer Clinical Trials Unit ( Site 0520)

    London, London, City of, NW1 2PG

    Study Coordinator, 07943 094 762

    Recruiting

  • Royal Free Hospital ( Site 0507)

    London, London, City of, NW3 2QG

    Active, not recruiting

  • Royal Marsden Hospital ( Site 0505)

    London, London, City of, SW3 6JJ

    Study Coordinator, +442078082132

    Recruiting

  • Sarah Cannon Research UK ( Site 0504)

    London, London, City of, W1G 6AD

    Completed

  • The Christie ( Site 0516)

    Manchester, England, M20 4BX

    Study Coordinator, 01614463000

    Recruiting

  • Nottingham University Hospitals NHS Trust ( Site 0510)

    Nottingham, Nottinghamshire, NG5 1PB

    Active, not recruiting

  • Royal Preston Hospital ( Site 0518)

    Preston, Lancashire, PR2 9HT

    Study Coordinator, 01772 524656

    Recruiting

  • Weston Park Hospital ( Site 0519)

    Sheffield, England, S10 2SJ

    Study Coordinator, 0114 2265000

    Recruiting

  • The Royal Marsden NHS Foundation Trust. ( Site 0513)

    Sutton, SM2 5PT

    Study Coordinator, +4402073528171

    Recruiting

  • New Cross Hospital-Department of Oncology ( Site 0517)

    Wolverhampton, WV10 0QP

    Active, not recruiting

Other trials in United Kingdom

Hungary18 sites, 17 recruiting

  • Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1411)

    Budapest, Pest County, 1122

    Study Coordinator, +36122486003162

    Recruiting

  • Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1406)

    Budapest, 1088

    Study Coordinator, +36202051965

    Recruiting

  • Orszagos Koranyi Pulmonologiai Intezet ( Site 1403)

    Budapest, 1121

    Study Coordinator, +36302005233

    Recruiting

  • Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1413)

    Budapest, 1145

    Study Coordinator, +36 1 467 3700

    Recruiting

  • Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 1415)

    Debrecen, 4032

    Study Coordinator, +36 52 255 196

    Recruiting

  • Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1412)

    Debrecen, 4032

    Study Coordinator, +36 52 512 701

    Recruiting

  • Farkasgyepui Tudogyogyintezet-Pulmonologia ( Site 1414)

    Farkasgyepű, Veszprém megye, 8582

    Completed

  • Mátrai Gyógyintézet ( Site 1417)

    Gyöngyös, Heves County, 3233

    Study Coordinator, +36203929250

    Recruiting

  • Petz Aladar Egyetemi Oktato Korhaz-Pulmonológia (Dr. Szalai Zsuzsanna) ( Site 1408)

    Győr, Győr-Moson-Sopron, 9024

    Study Coordinator, +3696507900

    Recruiting

  • Békés Megyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 1405)

    Gyula, Bekes County, 5700

    Study Coordinator, +3666526526

    Recruiting

  • Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1402)

    Kaposvár, 7400

    Study Coordinator, +36304805269

    Recruiting

  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1419)

    Kecskemét, Bács-Kiskun county, 6000

    Study Coordinator, +3676519853

    Recruiting

  • Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház ( Site 1409)

    Miskolc, Borsod-Abauj Zemplen county, 3526

    Study Coordinator, +36304719966

    Recruiting

  • Fejér Megyei Szent György Egyetemi Oktató Kórház-l.Pulmonologia ( Site 1407)

    Székesfehérvár, Fejér, 8000

    Study Coordinator, +36309513053

    Recruiting

  • Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 1401)

    Szolnok, Jász-Nagykun-Szolnok, 5000

    Study Coordinator, +36209323256

    Recruiting

  • Markusovszky Egyetemi Oktatokorhaz-Onkológiai Osztály ( Site 1410)

    Szombathely, Vas County, 9700

    Study Coordinator, +36204714153

    Recruiting

  • Reformatus Pulmonologiai Centrum ( Site 1418)

    Törökbálint, Pest County, 2045

    Study Coordinator, +3623511580

    Recruiting

  • Zala Megyei Szent Rafael Korhaz ( Site 1400)

    Zalaegerszeg, 8900

    Study Coordinator, +3692501527

    Recruiting

Other trials in Hungary

Chile16 sites, 15 recruiting

  • Bradford Hill Norte ( Site 2761)

    Antofagasta, 1263521

    Study Coordinator, +56974944605

    Recruiting

  • Biocenter ( Site 2763)

    Concepción, Biobio, 4070196

    Study Coordinator, +56412858421

    Recruiting

  • IC La Serena Research ( Site 2766)

    La Serena, Coquimbo Region, 1720430

    Study Coordinator, +56958646664

    Recruiting

  • Centro de Estudios Clínicos SAGA ( Site 2767)

    Santiago, Region M. de Santiago, 7500653

    Study Coordinator, +562223592703

    Recruiting

  • Orlandi Oncologia-Oncology ( Site 2752)

    Santiago, Region M. de Santiago, 7500713

    Completed

  • Fundacion Arturo Lopez Perez FALP ( Site 2750)

    Santiago, Region M. de Santiago, 7500921

    Study Coordinator, +56992108354

    Recruiting

  • Oncovida ( Site 2759)

    Santiago, Region M. de Santiago, 7500994

    Study Coordinator, 56225992945

    Recruiting

  • Clínica Inmunocel ( Site 2762)

    Santiago, Region M. de Santiago, 7580206

    Study Coordinator, +56997890202

    Recruiting

  • Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 2751)

    Santiago, Region M. de Santiago, 8330024

    Study Coordinator, +56963413803

    Recruiting

  • Instituto Nacional del Cancer-CR Investigación ( Site 2753)

    Santiago, Region M. de Santiago, 8380455

    Study Coordinator, +56 2575 7100

    Recruiting

  • Bradfordhill-Clinical Area ( Site 2756)

    Santiago, Region M. de Santiago, 8420383

    Study Coordinator, +56229490970

    Recruiting

  • UNIVERSIDAD CATÓLICA DEL MAULE ( Site 2768)

    Talca, Maule Region, 3465584

    Study Coordinator, +56712635600

    Recruiting

  • James Lind Centro de Investigacion del Cancer ( Site 2757)

    Temuco, Araucania, 4800827

    Study Coordinator, +56956083262

    Recruiting

  • CIDO SpA ( Site 2765)

    Temuco, Araucania, 4810148

    Study Coordinator, +56452657374

    Recruiting

  • ONCOCENTRO APYS-ACEREY ( Site 2758)

    Viña del Mar, Valparaiso, 2520598

    Study Coordinator, +56323320850

    Recruiting

  • Centro de Investigaciones ( Site 2755)

    Viña del Mar, Valparaiso, 2540488

    Study Coordinator, +56323245375

    Recruiting

Other trials in Chile

Germany14 sites

  • Charite Universitätsmedizin Berlin Campus Benjamin Franklin ( Site 2424)

    Berlin, 12203

    Active, not recruiting

  • Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 2418)

    Berlin, 14165

    Completed

  • Elbe Klinikum Buxtehude ( Site 2400)

    Buxtehude, Lower Saxony, 21614

    Completed

  • Universitatsklinikum Carl Gustav Carus ( Site 2407)

    Dresden, Saxony, 01307

    Completed

  • Universitätsklinikum Erlangen ( Site 2408)

    Erlangen, Bavaria, 91054

    Completed

  • Universitaetsklinikum Essen ( Site 2404)

    Essen, North Rhine-Westphalia, 45147

    Completed

  • Krankenhaus Nordwest ( Site 2409)

    Frankfurt am Main, Hesse, 60488

    Completed

  • SRH Wald-Klinikum Gera GmbH ( Site 2403)

    Gera, Thuringia, 07548

    Completed

  • LungenClinic Grosshansdorf GmbH ( Site 2412)

    Großhansdorf, Schleswig-Holstein, 22927

    Completed

  • Facharztzentrum Eppendorf ( Site 2415)

    Hamburg, 20249

    Completed

  • Medizinische Hochschule Hannover ( Site 2402)

    Hanover, Lower Saxony, 30625

    Completed

  • Universitaetsklinikum des Saarlandes-Klinik für Innere Medizin V-Pneumologie, Allergologie, Beatmun ( Site 2411)

    Homburg, Saarland, 66424

    Completed

  • Universitaetsklinik Muenchen ( Site 2406)

    Munich, Bavaria, 80337

    Completed

  • Universitaetsklinikum Tuebingen ( Site 2405)

    Tübingen, Baden-Wurttemberg, 72076

    Completed

Other trials in Germany

Mexico14 sites, 9 recruiting

  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 1109)

    Chihuahua City, 31123

    Study Coordinator, 52 6143458712

    Recruiting

  • Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, S.C. ( Site 1119)

    Ciudad Madero, Tamaulipas, 89440

    Study Coordinator, +528331260055

    Recruiting

  • Centro de Inmuno Oncología de Occidente SA de CV ( Site 1115)

    Guadalajara, Jalisco, 44630

    Study Coordinator, +523332592394

    Recruiting

  • Investigación Oncofarmacéutica-Investigación clínica ( Site 1114)

    La Paz, Baja California Sur, 23040

    Study Coordinator, 52 6121297171

    Recruiting

  • Medical Care and Research SA de CV ( Site 1103)

    Mérida, Yucatán, 97070

    Completed

  • Arke Estudios Clinicos ( Site 1117)

    Mexico City, Mexico City, 06700

    Active, not recruiting

  • INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1102)

    Mexico City, Mexico City, 14080

    Study Coordinator, +52 55 1315-0894

    Recruiting

  • Oncare Viaducto Napoles ( Site 1107)

    Mexico City, 03810

    Completed

  • Avix Investigación Clinica, S.C.-Oncology ( Site 1104)

    Monterrey, Nuevo León, 64623

    Study Coordinator, 8181431112

    Recruiting

  • I Can Oncology Center SA de CV ( Site 1116)

    Monterrey, Nuevo León, 64710

    Active, not recruiting

  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 1113)

    Monterrey, Nuevo León, 66460

    Study Coordinator, 52 8183338111

    Recruiting

  • Oaxaca Site Management Organization ( Site 1106)

    Oaxaca City, Oaxaca, 68000

    Study Coordinator, +52 951 229-0849

    Recruiting

  • Cuidados Oncologicos. ( Site 1118)

    Querétaro, 76000

    Active, not recruiting

  • Centro de Urologa Avanzada del Noreste ( Site 1110)

    San Pedro Garza García, Nuevo León, 66269

    Study Coordinator, 52 8183631717

    Recruiting

Other trials in Mexico

Israel13 sites, 6 recruiting

  • Emek Medical Center ( Site 2072)

    Afula, 1834111

    Study Coordinator, 9724649572

    Recruiting

  • Rambam Health Care Campus-Oncology Division ( Site 2053)

    Haifa, 3109601

    Study Coordinator, +97247773811

    Recruiting

  • Bnai Zion Medical Center ( Site 2060)

    Haifa, 3339419

    Completed

  • Shaare Zedek Medical Center ( Site 2068)

    Jerusalem, 9103102

    Study Coordinator, +97226555999

    Recruiting

  • Hadassah Ein Kerem Medical Center ( Site 2051)

    Jerusalem, 9112001

    Active, not recruiting

  • Rabin Medical Center ( Site 2059)

    Petah Tikva, 49100

    Study Coordinator, +97239378076

    Recruiting

  • Chaim Sheba Medical Center. ( Site 2052)

    Ramat Gan, 5224213

    Active, not recruiting

  • Chaim Sheba Medical Center ( Site 2055)

    Ramat Gan, 5262000

    Study Coordinator, +97235307096

    Recruiting

  • Sheba Medical Center ( Site 2062)

    Ramat Gan, 5265601

    Completed

  • Sheba Medical Center ( Site 2065)

    Ramat Gan, 5265601

    Active, not recruiting

  • ZIV Medical Center-Hematology Institute ( Site 2061)

    Safed, 1311001

    Completed

  • Sourasky Medical Center ( Site 2054)

    Tel Aviv, 6423906

    Study Coordinator, +97236973082

    Recruiting

  • Shamir Medical Center Assaf Harofeh ( Site 2058)

    Ẕerifin, 6093000

    Completed

Other trials in Israel

Taiwan12 sites, 12 recruiting

  • Changhua Christian Hospital ( Site 3210)

    Changhua, 50006

    Study Coordinator, +88647238595

    Recruiting

  • National Taiwan University Hospital - Hsinchu branch ( Site 3208)

    Hsinchu, 300195

    Study Coordinator, +88635326151

    Recruiting

  • Kaohsiung Chang Gung Memorial Hospital ( Site 3203)

    Kaohsiung City, 83301

    Study Coordinator, +886975056230

    Recruiting

  • China Medical University Hospital ( Site 3204)

    Taichung, 40447

    Study Coordinator, +886975681629

    Recruiting

  • Taichung Veterans General Hospital ( Site 3209)

    Taichung, 40705

    Study Coordinator, +886423592525x3219

    Recruiting

  • National Cheng Kung University Hospital ( Site 3201)

    Tainan, 70457

    Study Coordinator, 886-6-235-3535x5401

    Recruiting

  • National Taiwan University Hospital ( Site 3200)

    Taipei, 10048

    Study Coordinator, +8862232123456

    Recruiting

  • Mackay Memorial Hospital ( Site 3205)

    Taipei, 10449

    Study Coordinator, +886225433535

    Recruiting

  • Taipei Medical University Hospital ( Site 3211)

    Taipei, 110

    Study Coordinator, +886227372181

    Recruiting

  • Taipei Veterans General Hospital ( Site 3202)

    Taipei, 11217

    Study Coordinator, +886228712121

    Recruiting

  • Koo Foundation Sun Yat-Sen Cancer Center-Gynecology, Obstetrics, and women's health ( Site 3207)

    Taipei, 112

    Study Coordinator, +886228970011x1686

    Recruiting

  • Chang Gung Medical Foundation-Linkou Branch ( Site 3206)

    Taoyuan, 33305

    Study Coordinator, +88633281200x8468

    Recruiting

Other trials in Taiwan

Belgium10 sites

  • Institut Jules Bordet ( Site 2903)

    Anderlecht, Bruxelles-Capitale, Region de, 1070

    Completed

  • Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 2905)

    Brussels, Bruxelles-Capitale, Region de, 1070

    Completed

  • UZ Brussel ( Site 2900)

    Brussels, Bruxelles-Capitale, Region de, 1090

    Completed

  • Cliniques universitaires Saint-Luc-Medical Oncology ( Site 2911)

    Brussels, Bruxelles-Capitale, Region de, 1200

    Completed

  • AZ Maria Middelares ( Site 2908)

    Ghent, Oost-Vlaanderen, 9000

    Completed

  • UZ Leuven ( Site 2901)

    Leuven, Vlaams-Brabant, 3000

    Completed

  • UZ Leuven - Campus Gasthuisberg ( Site 2906)

    Leuven, Vlaams-Brabant, 3000

    Active, not recruiting

  • UZ Leuven Gasthuisberg, Gynaecologie-Verloskunde ( Site 2907)

    Leuven, Vlaams-Brabant, 3000

    Completed

  • AZ Sint-Maarten ( Site 2904)

    Mechelen, Antwerpen, 2800

    Completed

  • Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 2909)

    Namur, 5530

    Active, not recruiting

Other trials in Belgium

Colombia10 sites, 10 recruiting

  • Clinica de la Costa S.A.S. ( Site 2705)

    Barranquilla, Atlántico, 080020

    Study Coordinator, +57 6053369999x229

    Recruiting

  • Instituto Nacional De Cancerologia-Oncología Clínica ( Site 2706)

    Bogota, Cundinamarca, 111151

    Study Coordinator, +576014320160

    Recruiting

  • Administradora Country SA - Clinica del Country ( Site 2701)

    Bogotá, Bogota D.C., 110221

    Study Coordinator, +573174236866

    Recruiting

  • Fundación Valle del Lili ( Site 2700)

    Cali, Valle del Cauca Department, 760032

    Study Coordinator, +576023319090Ext7760

    Recruiting

  • Clínica Imbanaco S.A.S ( Site 2708)

    Cali, Valle del Cauca Department, 760042

    Study Coordinator, +576023851000

    Recruiting

  • Promotora Médica Las Américas S.A. ( Site 2702)

    Medellín, Antioquia, 050024

    Study Coordinator, 574 3409393 ext 5329

    Recruiting

  • Fundacion Colombiana de Cancerología Clinica Vida ( Site 2707)

    Medellín, Antioquia, 050030

    Study Coordinator, +57 3134336816

    Recruiting

  • IMAT S.A.S ( Site 2703)

    Montería, Departamento de Córdoba, 230002

    Study Coordinator, +573135342052

    Recruiting

  • Oncologos del Occidente ( Site 2709)

    Pereira, Risaralda Department, 660001

    Study Coordinator, +573114746650

    Recruiting

  • Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2704)

    Valledupar, Cesar Department, 200001

    Study Coordinator, 573015371818

    Recruiting

Other trials in Colombia

Austria7 sites, 4 recruiting

  • Medical University of Graz ( Site 2952)

    Graz, Styria, 8036

    Study Coordinator, +4331638580321

    Recruiting

  • Medizinische Universitaet Innsbruck ( Site 2951)

    Innsbruck, Tyrol, 6020

    Study Coordinator, +4351250422971

    Recruiting

  • Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 2957)

    Linz, Upper Austria, 4020

    Study Coordinator, +4373276764226

    Recruiting

  • Kepler Universitätsklinikum ( Site 2955)

    Linz, Upper Austria, 4021

    Completed

  • Uniklinikum Salzburg ( Site 2956)

    Salzburg, 5020

    Completed

  • Medizinische Universität Wien ( Site 2953)

    Vienna, 1090

    Completed

  • Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2954)

    Vienna, 1210

    Study Coordinator, +431277003855

    Recruiting

Other trials in Austria

South Africa7 sites, 7 recruiting

  • Cape Town Oncology Trials ( Site 2007)

    Cape Town, Western Cape, 7570

    Study Coordinator, +27219443832

    Recruiting

  • The Oncology Centre ( Site 2000)

    Durban, KwaZulu-Natal, 4091

    Study Coordinator, +27312088666

    Recruiting

  • GVI Oncology ( Site 2008)

    George, Western Cape, 6520

    Study Coordinator, +448840806

    Recruiting

  • WCR Office ( Site 2002)

    Johannesburg, Gauteng, 2193

    Study Coordinator, +27113390600

    Recruiting

  • Wilgers Oncology Centre ( Site 2006)

    Pretoria, Gauteng, 0040

    Study Coordinator, +27128072744

    Recruiting

  • LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2005)

    Pretoria, Gauteng, 0181

    Study Coordinator, +27123466701

    Recruiting

  • Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 2004)

    Sandton, Gauteng, 2196

    Study Coordinator, +27118830900

    Recruiting

Other trials in South Africa

Czechia6 sites, 4 recruiting

  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0703)

    Brno, Brno-mesto, 656 53

    Study Coordinator, +420543132216

    Recruiting

  • Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0704)

    Olomouc, Olomouc Region, 779 00

    Study Coordinator, +420 588 444 288

    Recruiting

  • Fakultni nemocnice Olomouc ( Site 0701)

    Olomouc, 779 00

    Study Coordinator, +420588441671

    Recruiting

  • Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 0702)

    Prague, Praha 4, 140 59

    Study Coordinator, +420261082531

    Recruiting

  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0705)

    Prague, Praha 5, 150 06

    Active, not recruiting

  • Fakultni nemocnice v Motole ( Site 0700)

    Prague, 150 06

    Completed

Other trials in Czechia

Malaysia6 sites, 5 recruiting

  • Gleneagles Penang ( Site 0625)

    George Town, Pulau Pinang, 10050

    Study Coordinator, +6042229189

    Recruiting

  • Hospital Pulau Pinang ( Site 0629)

    George Town, Pulau Pinang, 10990

    Study Coordinator, +6042225333

    Recruiting

  • Pantai Hospital Kuala Lumpur ( Site 0628)

    Kuala Lumpur, 59100

    Completed

  • University Malaya Medical Centre ( Site 0626)

    Kuala Lumpur, 59100

    Study Coordinator, +60379492120

    Recruiting

  • Hospital Tengku Ampuan Afzan ( Site 0627)

    Kuantan, Pahang, 25100

    Study Coordinator, +6095706400

    Recruiting

  • Institut Kanser Negara - National Cancer Institute ( Site 0630)

    Putrajaya - Wilayah Persekutuan, Putrajaya, 62250

    Study Coordinator, +60123304499

    Recruiting

Other trials in Malaysia

Romania6 sites, 6 recruiting

  • MEMORIAL HEALTHCARE INTERNATIONAL S.R.L ( Site 3553)

    Bucharest, Bucharest, 013823

    Study Coordinator, +40319393

    Recruiting

  • Cardiomed SRL Cluj-Napoca ( Site 3555)

    Cluj-Napoca, Cluj, 400015

    Study Coordinator, +40264406600

    Recruiting

  • Institutul Oncologic "Prof. Dr. Ioan Chiricuta" ( Site 3551)

    Cluj-Napoca, 400015

    Study Coordinator, +0264 598 362

    Recruiting

  • Centrul de Oncologie "Sfântul Nectarie" ( Site 3552)

    Craiova, Dolj, 200347

    Study Coordinator, +40731604432

    Recruiting

  • Spitalul Județean Sfântul Ioan cel Nou Suceava-Oncology ( Site 3550)

    Suceava, 720237

    Study Coordinator, +40722423653

    Recruiting

  • Cabinet Medical Oncomed ( Site 3554)

    Timișoara, Timiș County, 300239

    Study Coordinator, +40356460996

    Recruiting

Other trials in Romania

Netherlands5 sites, 4 recruiting

  • Antoni van Leeuwenhoek Ziekenhuis ( Site 1551)

    Amsterdam, North Holland, 1066 CX

    Study Coordinator, +31205129111

    Recruiting

  • Amsterdam UMC, locatie VUmc ( Site 1555)

    Amsterdam, North Holland, 1081 HV

    Study Coordinator, +310204444321

    Recruiting

  • Universitair Medisch Centrum Groningen ( Site 1550)

    Groningen, 9713GZ

    Study Coordinator, +31503616161

    Recruiting

  • Radboud University Medical Center ( Site 1554)

    Nijmegen, Gelderland, 6525 GA

    Study Coordinator, +31243610353

    Recruiting

  • Erasmus MC ( Site 1553)

    Rotterdam, South Holland, 3015 GD

    Completed

Other trials in Netherlands

New Zealand5 sites, 3 recruiting

  • Auckland City Hospital ( Site 1503)

    Auckland, 1023

    Study Coordinator, +6493670000

    Recruiting

  • Canterbury Regional Cancer & Blood Service ( Site 1500)

    Christchurch, Canterbury, 8011

    Active, not recruiting

  • Waikato Hospital ( Site 1502)

    Hamilton, Waikato Region, 3204

    Active, not recruiting

  • Palmerston North Hospital, MidCentral DHB ( Site 1504)

    Palmerston North, Manawatu-Wanganui, 4442

    Study Coordinator, +6463507486

    Recruiting

  • Capital & Coast District Health Board - Wellington Hospital ( Site 1501)

    Wellington, 6021

    Study Coordinator, +6449186109

    Recruiting

Other trials in New Zealand

Thailand5 sites, 4 recruiting

  • Ramathibodi Hospital. ( Site 2364)

    Bangkok, Bangkok, 10400

    Study Coordinator, +6622011671

    Recruiting

  • Faculty of Medicine Siriraj Hospital ( Site 2365)

    Bangkoknoi, Bangkok, 10700

    Study Coordinator, +6624194488

    Recruiting

  • Songklanagarind Hospital ( Site 2367)

    Hat Yai, Changwat Songkhla, 90110

    Study Coordinator, +6674451469

    Recruiting

  • Faculty of Medicine - Khon Kaen University ( Site 2366)

    Muang, Changwat Khon Kaen, 40002

    Completed

  • Chulalongkorn University ( Site 2363)

    Pathumwan, Bangkok, 10330

    Study Coordinator, +6622516704

    Recruiting

Other trials in Thailand

Greece4 sites, 3 recruiting

  • General Hospital of Athens "Laiko"-Hematology Department ( Site 1851)

    Athens, Attica, 115 27

    Study Coordinator, 0030 2136060981

    Recruiting

  • Sotiria Regional Chest Diseases Hospital of Athens ( Site 1850)

    Athens, Attica, 115 27

    Completed

  • Andreas Syggros Hospital ( Site 1853)

    Athens, Attica, 161 21

    Study Coordinator, 0030 2107210839

    Recruiting

  • European Interbalkan Medical Center ( Site 1855)

    Thessaloniki, 570 01

    Study Coordinator, 0030 2310400213

    Recruiting

Other trials in Greece

Guatemala4 sites, 4 recruiting

  • MEDI-K ( Site 3403)

    Guatemala City, 01009

    Study Coordinator, +5022291-2323

    Recruiting

  • CELAN,S.A ( Site 3405)

    Guatemala City, 01010

    Study Coordinator, +5022783107

    Recruiting

  • Oncomedica ( Site 3401)

    Guatemala City, 01010

    Study Coordinator, +50222781269

    Recruiting

  • Grupo Medico Angeles ( Site 3402)

    Guatemala City, 01015

    Study Coordinator, +50223857572

    Recruiting

Other trials in Guatemala

Portugal4 sites

  • Champalimaud Foundation ( Site 1751)

    Lisbon, Lisbon District, 1400-038

    Active, not recruiting

  • Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 1750)

    Lisbon, 1769-001

    Active, not recruiting

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE-Oncologia Médica ( Site 1753)

    Porto, 4200-072

    Active, not recruiting

  • Centro Hospitalar de Sao Joao - Hospital de Sao Joao ( Site 1752)

    Porto, 4200-319

    Completed

Other trials in Portugal

Sweden4 sites, 2 recruiting

  • Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 0803)

    Gothenburg, Västra Götaland County, 413 45

    Completed

  • Karolinska Universitetssjukhuset Solna ( Site 0802)

    Stockholm, Stockholm County, 171 76

    Study Coordinator, +46851770000

    Recruiting

  • Norrlands Universitetssjukhus ( Site 0800)

    Umeå, Västerbotten County, 901 85

    Completed

  • Blod och Tumorssjukdomar. Akademiska sjukhuset ( Site 0801)

    Uppsala, Uppsala County, 751 85

    Study Coordinator, +46186110000

    Recruiting

Other trials in Sweden

Hong Kong3 sites, 2 recruiting

  • Queen Mary Hospital ( Site 1902)

    Hksar

    Study Coordinator, 8522255435

    Recruiting

  • Queen Mary Hospital-Department of Medicine (Respiratory) ( Site 1900)

    Hksar

    Completed

  • Princess Margaret Hospital ( Site 1903)

    Hong Kong

    Study Coordinator, +852 2990 1111

    Recruiting

Other trials in Hong Kong

Ireland3 sites, 3 recruiting

  • Mater Misercordiae University Hospital ( Site 1800)

    Dublin, Leinster, DO7R2DWY

    Study Coordinator, +353 1 803 2000

    Recruiting

  • Tallaght University Hospital ( Site 1803)

    Dublin, D24 NR0A

    Study Coordinator, +35314144209

    Recruiting

  • St. James s Hospital ( Site 1801)

    Dublin, Dublin 8

    Study Coordinator, +35314103000

    Recruiting

Other trials in Ireland

Lithuania3 sites, 2 recruiting

  • Klaipeda University Hospital-Oncology chemotherapy ( Site 3302)

    Klaipėda, Klaipedos Miestas, 92288

    Completed

  • Vilniaus Universiteto Ligonine Santaros Klinikos ( Site 3300)

    Vilnius, 08460

    Study Coordinator, +37068388052

    Recruiting

  • Vilnius University Hospital Santaros Clinics Affiliate - National Cancer Center ( Site 3301)

    Vilnius, LT-08406

    Study Coordinator, +37061129056

    Recruiting

Other trials in Lithuania

Norway3 sites, 3 recruiting

  • Helse Bergen Haukeland universitetssykehus ( Site 1451)

    Bergen, Vestfold, 5021

    Study Coordinator, +4755974200

    Recruiting

  • Oslo Universitetssykehus Radiumhospitalet ( Site 1450)

    Oslo, 0379

    Study Coordinator, +4722934809

    Recruiting

  • Oslo universitetssykehus, Radiumhospitalet ( Site 1452)

    Oslo, 0379

    Study Coordinator, +47 23026600

    Recruiting

Other trials in Norway

Peru3 sites, 2 recruiting

  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0678)

    Lima, 15036

    Study Coordinator, +51012241598 Ext 121

    Recruiting

  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0681)

    Lima, 15038

    Study Coordinator, +51012016500 Ext3009

    Recruiting

  • Hospital Cayetano Heredia-Oncology ( Site 0675)

    Lima, 15102

    Completed

Other trials in Peru

Philippines3 sites, 2 recruiting

  • Makati Medical Center ( Site 1702)

    Makati City, National Capital Region, 1229

    Study Coordinator, 639178990272

    Recruiting

  • Lung Center of the Philippines ( Site 1705)

    Quezon City, National Capital Region, 1100

    Completed

  • St. Luke s Medical Center ( Site 1700)

    Quezon City, National Capital Region, 1102

    Study Coordinator, +639175431178

    Recruiting

Other trials in Philippines

Puerto Rico3 sites

  • Ad-Vance Medical Research-Research ( Site 1151)

    Ponce, 00717

    Completed

  • FDI Clinical Research ( Site 1152)

    San Juan, 00927

    Completed

  • UPR Comprehensive Cancer Center ( Site 1150)

    San Juan, 00935

    Completed

Other trials in Puerto Rico

Switzerland3 sites

  • University Hospital Basel ( Site 0752)

    Basel, Canton of Basel-City, 4031

    Active, not recruiting

  • Hôpitaux Universitaires de Genève (HUG) ( Site 0753)

    Geneva, Canton of Geneva, 1211

    Active, not recruiting

  • Universitaetsspital Zuerich ( Site 0750)

    Zürich-Flughafen, Canton of Zurich, 8058

    Active, not recruiting

Other trials in Switzerland

Vietnam3 sites

  • Hanoi Oncology Hospital ( Site 3780)

    Hanoi, Hanoi, 100000

    Active, not recruiting

  • K Hospital - National Cancer Hospital ( Site 3783)

    Hanoi, Hanoi, 100000

    Active, not recruiting

  • National Lung Hospital ( Site 3781)

    Hanoi, Hanoi, 100000

    Completed

Other trials in Vietnam

Costa Rica2 sites, 1 recruiting

  • CIMCA ( Site 3900)

    San José, 10103

    Study Coordinator, +50683893636

    Recruiting

  • Hospital Metropolitano - Sede Lindora ( Site 3901)

    Santa Ana, Provincia de San José, 10903

    Active, not recruiting

Other trials in Costa Rica

Denmark2 sites, 1 recruiting

  • Odense Universitetshospital ( Site 0650)

    Odense, Region Syddanmark, 5000

    Active, not recruiting

  • Vejle Sygehus ( Site 0653)

    Vejle, Region Syddanmark, 7100

    Study Coordinator, +45 79405000

    Recruiting

Other trials in Denmark

Finland2 sites

  • Tampere University Hospital [Tampere Finland] ( Site 0600)

    Tampere, Pirkanmaa, 33520

    Suspended

  • Turku University Hospital ( Site 0601)

    Turku, Southwest Finland, 20520

    Suspended

Other trials in Finland

Latvia2 sites, 2 recruiting

  • Liepjas reionl slimnca ( Site 3851)

    Liepāja, LV-3414

    Study Coordinator, +371 26351999

    Recruiting

  • RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia-Out-patient and Day patient facility of Ch ( Site 3850)

    Riga, LV1079

    Study Coordinator, +37126594570

    Recruiting

Other trials in Latvia

Singapore2 sites, 2 recruiting

  • National Cancer Centre Singapore ( Site 2200)

    Singapore, Central Singapore, 168583

    Study Coordinator, +6564368000

    Recruiting

  • National University Hospital-Haematology -Oncology Research Group ( Site 2201)

    Singapore, South West, 119074

    Study Coordinator, +6567726825

    Recruiting

Other trials in Singapore

Estonia1 site

  • Tartu University Hospital-Radiotherapy and oncology ( Site 3800)

    Tartu, Tartu, 50406

    Active, not recruiting

Other trials in Estonia

About this study

Official title: A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study.

This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the parent study. Participants who were in the First Course Phase of study treatment with pembrolizumab or lenvatinib in their parent study will enter the First Course Phase of this study and complete up to 35 doses or more every 3 weeks (Q3W) or 17 doses or more every 6 weeks (Q6W) of study treatment with pembrolizumab or a pembrolizumab-based combination or lenvatinib according to arm assignment. Participants who were in the Follow-up Phase in the parent study (post-treatment or Survival Follow-up Phase) will enter the Survival Follow-up Phase of this study. Participants who were in the Second Course Phase in their parent study will enter Second Course Phase of this study and complete up to 17 doses Q3W or 8 doses Q6W of study treatment with pembrolizumab or a pembrolizumab-based combination according to arm assignment.

Any participant originating from a parent trial where crossover to pembrolizumab was permitted upon disease progression may be eligible for 35 doses as Q3W or 17 doses Q6W of pembrolizumab (approximately 2 years), if they progress while on the control arm and pembrolizumab is approved for the indication in the country where the potential eligible crossover participant is being evaluated.

Being tested
Pembrolizumab, Standard of Care (SOC), Lenvatinib, Olaparib, MK-4280
Keywords
PD1, PD-1, PDL1, PD-L1
Medical subject headings
Hematologic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PembrolizumabDrug

    Also called MK-3475, KEYTRUDA®

    200 or 400 mg IV infusion

  • Standard of Care (SOC)Drug

    IV infusion or oral tablets

  • LenvatinibDrug

    Oral capsules

  • OlaparibDrug

    Also called Lynparza

    300mg or 250mg or 100mg oral tablers

  • MK-4280Drug

    Also called Favezelimab

    IV Infusion

  • MK-4280ABiological

    800mg favezelimab + 200mg pembrolizumab IV Infusion

  • Pembrolizumab (+) Berahyaluronidase alfaBiological

    Also called MK-3475A

    395 mg or 790 mg SC administration

Study groups in NCT03486873
Study groupRoleWhat they receive
Pembrolizumab 200 mgExperimentalParticipants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 3-week cycle for up to 35 administrations or more for First Course participants and up to 17 administrations for Second Course participants.
Receives: Drug: Pembrolizumab
Pembrolizumab 400 mgExperimentalParticipants receive pembrolizumab 400 mg via intravenous (IV) infusion on Day 1 of each 6-week cycle for up to 17 administrations or more for First Course participants and up to 8 administrations for Second Course participants.
Receives: Drug: Pembrolizumab
Pembrolizumab 200 mg + SOC: Per Parent Study)ExperimentalParticipants receive pembrolizumab 200 mg via IV infusion on Day 1 of each 3-week cycle PLUS standard of care (SOC) treatment (or per parent study if there is no SOC) for up to 35 administrations or more for First Course participants and up to 17 administrations for Second Course participants. Participants receiving a pembrolizumab-based combination treatment will receive the dose regimen of the combination drug(s) which is recommended per SOC or was used in the parent study protocol if there is no SOC recommendation.
Receives: Drug: Pembrolizumab; Drug: Standard of Care (SOC)
Pembrolizumab 400 mg + SOC (Per Parent Study)ExperimentalParticipants receive pembrolizumab 400 mg via IV infusion on Day 1 of each 6-week cycle PLUS SOC treatment (or per parent study if there is no SOC) for up to 17 administrations or more for First Course participants and up to 8 administrations for Second Course participants. Participants receiving a pembrolizumab-based combination treatment will receive the dose regimen of the combination drug(s) which is recommended per SOC or was used in the parent study protocol if there is no SOC recommendation.
Receives: Drug: Pembrolizumab; Drug: Standard of Care (SOC)
SOC (Per Parent Study)Active comparatorParticipants receive the dose matched non-pembrolizumab SOC treatment (e.g. chemotherapy) they were receiving as per parent study protocol.
Receives: Drug: Standard of Care (SOC)
Lenvatinib 20 mgExperimentalParticipants with body weight (BW)>60kg receive Lenvatinib 20mg orally once daily on a 21 or 42 day cycle. It is taken 0-4 hours after completion of pembrolizumabd administration in the clinic on cycle 1 day 1(C1D1), C2D1, C3D1, etc. Taken at home on all other days.
Receives: Drug: Lenvatinib
Lenvatinib 24 mgExperimentalParticipants with body weight (BW)>60 kg receive Lenvatinib 24 mg orally once daily on a 21 or 42 day cycle. It is taken 0-4 hours after completion of pembrolizumabd administration in the clinic on cycle 1 day 1(C1D1), C2D1, C3D1, etc. Taken at home on all other days.
Receives: Drug: Lenvatinib
Lenvatinib 12 mgExperimentalParticipants with body weight (BW)>60 kg receive Lenvatinib 12 mg orally once daily on a 21 or 42 day cycle. It is taken 0-4 hours after completion of pembrolizumabd administration in the clinic on cycle 1 day 1(C1D1), C2D1, C3D1, etc. Taken at home on all other days.
Receives: Drug: Lenvatinib
Lenvatinib 8 mgExperimentalParticipants with body weight (BW)<60 kg receive Lenvatinib 8 mg orally once daily on a 21 or 42 day cycle. It is taken 0-4 hours after completion of pembrolizumabd administration in the clinic on cycle 1 day 1(C1D1), C2D1, C3D1, etc. Taken at home on all other days.
Receives: Drug: Lenvatinib
Lenvatinib 2mgExperimentalParticipants with body weight (BW)<60 kg receive Lenvatinib 2 mg orally once daily on a 21 or 42 day cycle. It is taken 0-4 hours after completion of pembrolizumab administration in the clinic on cycle 1 day 1(C1D1), C2D1, C3D1, etc. Taken at home on all other days.
Receives: Drug: Lenvatinib
Olaparib 300mgExperimentalParticipants receive Olaparib 300 mg orally twice daily (BID) until disease progression or toxicity prohibits its administration.
Receives: Drug: Olaparib
Olaparib 250mgExperimentalParticipants receive Olaparib 250 mg orally twice daily (BID) until disease progression or toxicity prohibits its administration.
Receives: Drug: Olaparib
Olaparib 100mgExperimentalParticipants receive Olaparib 100 mg orally twice daily (BID) until disease progression or toxicity prohibits its administration.
Receives: Drug: Olaparib
MK-4280 800mgExperimentalParticipants receive MK-4280 800mg as IV infusion every 3 weeks (Q3W) and may continue study therapy until study treatment completion or may transition to pembrolizumab to complete their treatment.
Receives: Drug: MK-4280
MK-4280AExperimentalParticipants receive MK-4280A (800mg favezelimab + 200mg pembrolizumab) as IV infusion every 3 weeks (Q3W) and may continue study therapy until study treatment completion or may transition to pembrolizumab to complete their treatment.
Receives: Biological: MK-4280A
Pembrolizumab (+) Berahyaluronidase alfa 395 mgExperimentalParticipants receive 395 mg of a fixed-dose formulation of pembrolizumab and berahyaluronidase alfa via subcutaneous (SC) administration on Day 1 of each 3-week cycle for up to 35 administrations.
Receives: Biological: Pembrolizumab (+) Berahyaluronidase alfa
Pembrolizumab (+) Berahyaluronidase alfa 790 mgExperimentalParticipants receive 790 mg of a fixed-dose formulation of pembrolizumab and berahyaluronidase alfa via SC administration on Day 1 of each 6-week cycle for up to 35 administrations.
Receives: Biological: Pembrolizumab (+) Berahyaluronidase alfa

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall Survival (OS)

    OS is defined as the time from randomization or start of study treatment for non-randomized participants (on the parent study) to death due to any cause. Participants without documented death at the time of analysis will be censored at the date of the last known to be alive.

    Measured: Up to approximately 10 years

Secondary outcomes (7)

  1. Modified Progression Free Survival (PFS) Per Evaluation Criteria Used in the Parent Trial

    Modified PFS is defined as the time from randomization or start of study treatment for nonrandomized participants (on the parent study or this study) to the first documented disease progression per the evaluation criteria used in the parent study based on investigator assessment or death due to any cause, whichever occurs first. The censoring rule is modified that participants without modified PFS events at the time of the analysis will be censored at the date of last known to be alive.

    Measured: Up to approximately 10 years

  2. Modified Event Free Survival (EFS) Per Evaluation Criteria Used in the Parent Trial

    Modified EFS is defined as the time from randomization to disease progression that precludes surgery, local or distant recurrence, or death due to any cause, whichever occurs first. The censoring rule is modified that participants without documented modified EFS events at the time of the analysis will be censored at the date of last known to be alive.

    Measured: Up to approximately 10 years

  3. Number of Participants Who Experience Serious Adverse Events (SAEs)

    A SAE is defined as any untoward medical occurrence that, at any dose: Results in death, Is life-threatening, Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity or Is a congenital anomaly/birth defect. The number of participants who experience a SAE in this study will be presented.

    Measured: Up to approximately 42 months (Up to 90 days after last dose of study treatment)

  4. Number of Participants Who Experience Adverse Events of Special Interest (AEOSI)

    AEOSI for this study include selected preferred terms from Medical Dictionary for Regulatory Activities (MedDRA) version 20.1 for the following higher-level terms: Pneumonitis, Colitis, Hepatitis, Nephritis, Adrenal Insufficiency, Hypophysitis, Hyperthyroidism, Hypothyroidism, Thyroiditis, Type 1 Diabetes Mellitus, Severe Skin Reactions Including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): or If grade 3 or higher, Uveitis, Pancreatitis, Myositis, Guillain-Barre Syndrome, Myocarditis, Encephalitis, Sarcoidosis, Infusion Reactions and Myasthenic Syndrome. The number of participants who experience an AEOSI in this study will be presented.

    Measured: Up to approximately 40 months (Up to 30 days after last dose of study treatment)

  5. Number of Participants Who Experience Clinically Significant Adverse Events (CSAE)

    CSAE are AEs associated with lenvatinib treatment and include selected preferred terms from the lenvatinib CSAE preferred term list document. The number of participants who experience an CSAE in this study will be presented.

    Measured: Up to approximately 40 months (Up to 30 days after last dose of study treatment)

  6. Number of Participants Who Experience Events of Clinical Interest (ECI)

    ECIs for this study include: 1) An overdose of Sponsor's product, that is not associated with clinical symptoms or abnormal laboratory results or 2) An elevated aspartate aminotransferase (AST) or alanine aminotransferase (ALT) lab value that is ≥3X the upper limit of normal (ULN) and an elevated total bilirubin lab value that is ≥2X ULN and, at the same time, an alkaline phosphatase lab value that is <2X ULN, as determined by way of protocol-specified laboratory testing or unscheduled laboratory testing. The number of participants who experience an ECI in this study will be presented.

    Measured: Up to approximately 40 months (Up to 30 days after last dose of study treatment)

  7. Number of Participants Who Discontinue Study Treatment Due to an AE

    An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. The number of participants who discontinue study treatment due to an AE will be presented.

    Measured: Up to approximately 39 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2018
  2. Study start21 Aug 2018
  3. Primary completion4 Aug 2043 (estimated)
  4. Study completion4 Aug 2043 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03486873
Sponsor's protocol ID
3475-587
Other IDs
MK-3475-587, KEYNOTE-587, 195006, PHRR210209-002881, 2022-501254-10-00, jRCT2080224921, U1111-1274-2274, 2017-004417-42
Status last verified
Oct 2026
First submitted
29 Mar 2018
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Yes: https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf

Publications

  • Robert C, Carlino MS, McNeil C, Ribas A, Grob JJ, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance A, Daud AI, Hamid O, Larkin J, Anderson J, Krepler C, Grebennik D, Long GV. Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma. J Clin Oncol. 2023 Aug 20;41(24):3998-4003. doi: 10.1200/JCO.22.01599. Epub 2023 Jun 22.

    PubMed 37348035

  • Long GV, Carlino MS, McNeil C, Ribas A, Gaudy-Marqueste C, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance AM, Daud AI, Hamid O, Larkin J, Yao L, Singh R, Lal R, Robert C. Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study. Ann Oncol. 2024 Dec;35(12):1191-1199. doi: 10.1016/j.annonc.2024.08.2330. Epub 2024 Sep 15.

    PubMed 39306585

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in